Citrus Sinensis ID: 000483


Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-------990------1000------1010------1020------1030------1040------1050------1060------1070------1080------1090------1100------1110------1120------1130------1140------1150------1160------1170------1180------1190------1200------1210------1220------1230------1240------1250------1260------1270------1280------1290------1300------1310------1320------1330------1340------1350------1360------1370------1380------1390------1400------1410------1420------1430------1440------1450------1460----
MEEVVDWHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACRPINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFKANGISPEKSTVWETDGKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESNKLIKSIQVFLNALNELRLCHVMERSSSVPPKRESSKYVKHSGSSAKPRSTSAKARDVVATSNATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYKSLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWSKALEYYELQVRSDVMLQMDGNSGALSPHGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKSGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKSSGESINIYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESRSSNSRIILENYLKPAVSFSEDQRTTDKKSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKRLKSSTKGEKTDYSIKIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDEVQSYKFIPLVYQIASRMGSTKDALGLHNFQFALVSLVKKMAIDHPYHTIFQLLALANGDRIKDKQRSRNSFVVDMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELETRREQDTNKRIQLPREIRCLRQLELVPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKALQRQKEMDDDLETGLEGPEDEYEGNKDAERALIRVKQKLDGYEGGEMRSVHGQVQQLIQDAIDPERFCLMFPGWGAWL
ccccccccccHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHcccccccccccccccccccccccccccccccccHHHcccccccHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHcHHHHHHHHHccHHHHHHHHHHHHccccccHHHHHHHHHHHHccccccccccccccccccccHHHHHHHHHHHHHHccccHHHHHHHHHHHccHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHccccccccccccccHHHHHHccccccccccccccccccHHHHHHHHHHHcHHHHHHHHHHHHHHHccccccccccccccccccHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHccHHHHHHHHHHHHHccHHHHcccccccccccccccccccccccHHHHHHcccHHHHHHHHHHcccHHHHHHHHHccccccccccccHHHHHHHHHHHHHcccccccccccccccccccccccccHHHHHHHHHHHHHHccHHHHHHHHHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccHHHHHHHcccccccHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHcccHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHcccHHHHHHHccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHcccccHHHHHHHHHHHHcccccccHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHHHccHHHHHHHHHHHHcccHHHHHHHccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHccccccccccccccccccccccccccEEEEEccEEEEEccccccEEEEEEEcccccEEEEcccccccccHHHHHHHHHHHHHHHHcccccccccccccccccccccccccEEEEEcccccHHHHHHHHHHHcccccccccccccHHHHHHHHcccHHHHHHHHHHHHHHccHHHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccEEEEEcHHHHHHcccccccccccccccHHHHHHccccccccHHHHHHHHHHHHHHccHHHHHHHHHHHHccccccccccHHHHHHHHccccccccccccccccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHccHHHHHHHcccccccc
ccHHHcccccHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHcccccccEEEEEEccccEEEccccHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHcccccHHHHHHccHHcHHHHccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHccHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHcHHHHHHHHHHHccccccccHHHHccccccccccccHHHHHHHHHHccccccccEEcccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccHHHHHHHHHHHHHcccccHHHHHHcHccHHHHHHHHHHHccHHHHHHHHHHHHHcccccHHHHHcHHHHHHHcccHHHHHHHHHHHHHHccHHHHHHHHHHHHcHHHHHHHHHcccccccccccccHHHHHHHHHHHHHcccHHHHHHHHHHccccccccccccccHHHHHHHHHHHHccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHcccHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHcccHccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHccccccHHHHHccHHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHcccHHHHHHHHHHccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHcccHHHHccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccHHHcHHHcccccEcccccccccccccccccccEEEEEEcccEEEEEccccccEEEEEEcccccEEEEEEcccccHHHHHHHHHHHHHHHHHHHHccHHHHccccEEEEEEEEEccccccEEEEccccccHHHHHHHHHHHcccccccccccHHccccHHHccHHHHHHHHHHHHHcccccHHHHHHHHHcccHHHHHHHHHHHHHHHHHHHHHHHHEcccccccccEEEEccccEEEEEEcHHHHHHHcccccccccccHHHHHHHHHccccccccHHHHHHHHHHHHHHHcHHHHHHHHHHHHccccHHcccccHHHHHHccccccHHccccccccccHHHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHccHHHHHHHcccccccc
meevvdwhsdhdIVHAVWTLVHMCCSDDASSIRAWVSDFISrvgigdphcvvfhlprdsiymhacrpinhgsgsatefnfhldaGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFkangispekstvwetdgktfetwicpltysligcCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESNKLIKSIQVFLNALNELRLCHVmersssvppkresskyvkhsgssakprstsakarDVVATSNATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYksltlgspdfshletlPRHIEILVSAVtqinepdslyGIIQSHKLSSQIVTLEHEGNWSKALEYYELQVRSDVMlqmdgnsgalsphglpsvhlspstsenemmqrkpykgLMRSLQQVGCMHVLDMYCKGltswkgqfqhdpeftKLQYEAAWRtgnwdfslpylganfpsgqniksghfhENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGvawdirwkssgesiniypekqkivsepviptvgqlswlNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKflytgpgdqcstvyWLGRLEEAKLLRAQGQHEMAINLAKYISenyesneeapDVYRLVGKWLAesrssnsriilenylkpavsfsedqrttdkkSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKRLKsstkgektdYSIKIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIdevqsykfIPLVYQIASRMgstkdalgLHNFQFALVSLVKKMAIDHPYHTIFQLLALAngdrikdkqrsrnsfvvDMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELETRREQDTNKRIQLPREIRCLrqlelvpvvtatvpidctcqynegsfpyfKGLAESVMVMnginapkvvecfgsdghkyRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDtwkrrlgvrtykvvpftpsagilewvdgtvplgdyligstrnggahgrygigdwsfLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAfeqglmlktpervpfrltrdiidgmgvtgvEGVFRRCCEKTLSVMRTNKEALLTIVEVFIhdplykwalspLKALQRQKEMDddletglegpedeyegnkDAERALIRVKQKldgyeggemrsvHGQVQQLIQDAidperfclmfpgwgawl
MEEVVDWHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACRPINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERkfkangispekstvwetdgKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESNKLIKSIQVFLNALNELRLCHVMersssvppkresskyvkhsgssakprstsakardvvatsnatmttswdkVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYKSLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWSKALEYYELQVRSDVMLQMDGNSGALSPHGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKSGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKSSGESINIYpekqkivsepviPTVGQLSWLNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAEsrssnsriilenylkpavsfsedqRTTDKKSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKrlksstkgektdysiKIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDEVQSYKFIPLVYQIASRMGSTKDALGLHNFQFALVSLVKKMAIDHPYHTIFQLLALANGDRIKDKQRSRNSFVVDMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAEletrreqdtnkriqlpreirclrqlelVPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFlrnhrdtwkrrlgvrtykvvpftpsagilewVDGTVPLGDYLIGstrnggahgrYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFeqglmlktpervpfRLTRDIIDgmgvtgvegVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKALQRQKEMDDDLETglegpedeyegnkdaeRALIRVKQKLDGYEGGEMRSVHGQVQQLIQDAIDPERFCLMFPGWGAWL
MEEVVDWHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACRPINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFKANGISPEKSTVWETDGKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESNKLIKSIQVFLNALNELRLCHVMERSSSVPPKRESSKYVKHSGSSAKPRSTSAKARDVVATSNATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYKSLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWSKALEYYELQVRSDVMLQMDGNSGALSPHGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKSGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKSSGESINIYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESRSSNSRIILENYLKPAVSFSEDQRTTDKKSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKRLKSSTKGEKTDYSIKIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDEVQSYKFIPLVYQIASRMGSTKDALGLHNFQFALVSLVKKMAIDHPYHTIFQLLALANGDRIKDKQRSRNSFVVDMDKKlaaenlleelSSYHGAIIRQMKQMVDVYIKLAELETRREQDTNKRIQLPREIRCLRQLELVPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKALQRQKEMDDDLETGLEGPEDEYEGNKDAERALIRVKQKLDGYEGGEMRSVHGQVQQLIQDAIDPERFCLMFPGWGAWL
***VVDWHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACRPINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFKANGISPEKSTVWETDGKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESNKLIKSIQVFLNALNELRLCHVM***************************************NATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYKSLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWSKALEYYELQVRSDVML************************************LMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKSGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKSSGESINIYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESR**NSRIILENYLKPAV***************RQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKR********************************LLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDEVQSYKFIPLVYQIASRMGSTKDALGLHNFQFALVSLVKKMAIDHPYHTIFQLLALANGDRI********SFVVDMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELETR******KRIQLPREIRCLRQLELVPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAK***DDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLK******************************************Y******SVHGQVQQLIQDAIDPERFCLMFPGWGAW*
******WHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIY*****************NFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLL****************TVWETDGKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFT**********VFLNALNELRLCHVMERSSSVPPKRESSKYVKHSG*******************NATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCE******************LPRHIEILVSAVTQINEPDSLYGIIQSHKLSS*IV*****GNWSKALEYYELQVRSDVML*****SGALSPHGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKSGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRW***********EKQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHEL*************VYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESRSSNSRIILENYLKPAVSFS*********SIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKRLKSSTKGEKTDYSIKIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDEVQSYKFIPLVYQIASRMGSTKDALGLHNFQFALVSLVKKMAIDHPYHTIFQLLA*********************DKKLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELE**************REIRCLRQLELVP***************EGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWAL***********************EDEYEGNKDAERALIRVKQKLDGYEGGEMRSVHGQVQQLIQDAIDPERFCLMFPGWGAWL
********SDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACRPINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFKANGISPEKSTVWETDGKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESNKLIKSIQVFLNALNELRLCHVME*************************************SNATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYKSLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWSKALEYYELQVRSDVMLQMDGNSGALSPHGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKSGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKSSGESINIYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESRSSNSRIILENYLKPAVS*************ERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKRLK********DYSIKIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDEVQSYKFIPLVYQIASRMGSTKDALGLHNFQFALVSLVKKMAIDHPYHTIFQLLALANGDRIKDKQRSRNSFVVDMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELETRREQDTNKRIQLPREIRCLRQLELVPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKALQRQKEMDDDLETGLEGPEDEYEGNKDAERALIRVKQKLDGYEGGEMRSVHGQVQQLIQDAIDPERFCLMFPGWGAWL
MEEVVDWHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACRPINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFKANGISPEKSTVWETDGKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESNKLIKSIQVFLNALNELRLCHVMERSSSVPPKRE****V*********RSTSAKARDVVATSNATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHY*************ETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWSKALEYYELQVRSDVMLQMDGNSGALSPHGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSG****SGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKS***********QKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESRSSNSRIILENYLKPAVSFSEDQRTTDKKSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKRLKSSTKGEKTDYSIKIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDEVQSYKFIPLVYQIASRMGSTKDALGLHNFQFALVSLVKKMAIDHPYHTIFQLLALANGDRIKD**RSRNSFVVDMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELETRREQDTNKRIQLPREIRCLRQLELVPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKAL******************DEYEGNKDAERALIRVKQKLDGYEGGEMRSVHGQVQQLIQDAIDPERFCLMFPGWGAWL
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MEEVVDWHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACRPINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFKANGISPEKSTVWETDGKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQVQKYIFTESNKLIKSIQVFLNALNELRLCHVMERSSSVPPKRESSKYVKHSGSSAKPRSTSAKARDVVATSNATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYKSLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWSKALEYYELQVRSDVMLQMDGNSGALSPHGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKSGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKSSGESINIYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESRSSNSRIILENYLKPAVSFSEDQRTTDKKSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIELEALIKRLKSSTKGExxxxxxxxxxxxxxxxxxxxxxxxxxxxRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDEVQSYKFIPLVYQIASRMGSTKDALGLHNFQFALVSLVKKMAIDHPYHTIFQLLALANGDRIKDKQRSRNSFVVDMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELETRREQDTNKRIQLPREIRCLRQLELVPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKALQRQKEMDDDLETGLEGPEDEYEGNKDAERALIRVKQKLDGYEGGEMRSVHGQVQQLIQDAIDPERFCLMFPGWGAWL
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query1464 2.2.26 [Sep-21-2011]
Q9M3G73856 Serine/threonine-protein yes no 0.987 0.375 0.691 0.0
Q623883066 Serine-protein kinase ATM yes no 0.867 0.414 0.331 0.0
Q133153056 Serine-protein kinase ATM yes no 0.862 0.412 0.327 0.0
Q6PQD53057 Serine-protein kinase ATM yes no 0.857 0.410 0.327 0.0
Q4WVM72796 Serine/threonine-protein yes no 0.469 0.246 0.355 1e-122
Q4IB892813 Serine/threonine-protein yes no 0.703 0.366 0.292 1e-119
Q2U6392925 Serine/threonine-protein yes no 0.449 0.224 0.356 1e-115
O746302812 Serine/threonine-protein yes no 0.452 0.235 0.333 1e-114
Q5EAK62767 Serine/threonine-protein yes no 0.478 0.253 0.332 1e-113
Q5BHE22793 Serine/threonine-protein yes no 0.475 0.249 0.337 1e-113
>sp|Q9M3G7|ATM_ARATH Serine/threonine-protein kinase ATM OS=Arabidopsis thaliana GN=ATM PE=2 SV=1 Back     alignment and function desciption
 Score = 2092 bits (5419), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 1013/1465 (69%), Positives = 1209/1465 (82%), Gaps = 19/1465 (1%)

Query: 7    WHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACR 66
            W SD +IV+AVWTLV +  SD+A S+R  VSDF+SR+GI DPH VVFHLP + + MH  +
Sbjct: 2404 WQSDDEIVNAVWTLVRVSASDEADSMRLLVSDFLSRIGIRDPHTVVFHLPGNLVSMHGLQ 2463

Query: 67   PINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKG 126
               H +GS  +     + GIS+E LI +L  LKKYL+DDSV+I+D+TSQTLRGILSTE+G
Sbjct: 2464 GFGHNTGS--KVRSLTENGISDETLITLLNFLKKYLLDDSVKIIDVTSQTLRGILSTERG 2521

Query: 127  QRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFKANGISPEKSTVWETDGKTFET 186
            Q+A+ SFDS ER+L+EVH +GVN+++VE  LLD +++FKA   S E   VW TD K F+ 
Sbjct: 2522 QQALSSFDSCERALIEVHGRGVNLDIVEKILLDSQKQFKAEKFSLETPEVWSTDNKNFDR 2581

Query: 187  WICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQ 246
            WIC L Y +I  C DV +RLCQ+I LLK+E++ELL PSVVV+LAG   +D++L  LI+SQ
Sbjct: 2582 WICQLVYCMIALCEDVPIRLCQNIALLKAEISELLFPSVVVSLAGRIGMDINLHDLITSQ 2641

Query: 247  VQKYIFTESNKLIKSIQVFLNALNELRLCHVMERSS-SVPPKRESSKYVKHSGSSAKPRS 305
            V+++IFT+SNKL KS QV LN LNELR+C+V+ERS  S   KRE     K+S S     S
Sbjct: 2642 VKEHIFTDSNKLTKSKQVMLNTLNELRMCYVLERSIFSGQTKRE-----KNSRSC----S 2692

Query: 306  TSAKARDVVATSN---ATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEH 362
            T+AK RDV + SN   A++TT+W+KVYWLS+DYL VA SAV+CG+Y T+ MYVE+WCEE 
Sbjct: 2693 TAAKIRDVESGSNGMAASITTNWEKVYWLSIDYLVVAGSAVVCGAYLTASMYVEYWCEEK 2752

Query: 363  YKSLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWS 422
            + +L+LG PDFS+ + LP H+EILVSA+T+INEPDSLYG+I S+KLS+QI+T EHEGNW+
Sbjct: 2753 FGNLSLGDPDFSYHDKLPDHVEILVSAITRINEPDSLYGVIHSNKLSAQIITFEHEGNWT 2812

Query: 423  KALEYYELQVRSDVMLQMDGNSGALSPHGL-PSVHLSPSTSENEMMQRKPYKGLMRSLQQ 481
            +ALEYY+LQ RS  M+     S  L      P+     S      +QR+P+KGL+RSLQQ
Sbjct: 2813 RALEYYDLQARSQKMVVPSSLSENLEVEQFQPTTSARHSVFGEGEVQRQPFKGLIRSLQQ 2872

Query: 482  VGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKS 541
             GCMHVLD+YC+GLTS +G FQ+DPEF +LQYEAAWR G WDFSL Y   +    Q+ K+
Sbjct: 2873 TGCMHVLDLYCRGLTSREGCFQYDPEFIELQYEAAWRAGKWDFSLLYPQTHCQPLQHAKN 2932

Query: 542  GHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCH 601
             ++HE+LH CL AL+EGD + FY KLK +K+ELVLS++ ASEESTE+IYS +VKLQIL H
Sbjct: 2933 NNYHESLHCCLRALQEGDYDGFYGKLKDTKKELVLSISRASEESTEFIYSTVVKLQILHH 2992

Query: 602  LGVAWDIRWK-SSGESINIYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLE 660
            LG+ WD+RW  SS +S++ Y  KQ    +PVIPT+ QLSWLN +W+SI+ +TQLHM LLE
Sbjct: 2993 LGLVWDLRWTTSSHQSVHGYLVKQMACVDPVIPTMDQLSWLNKDWNSIITQTQLHMTLLE 3052

Query: 661  PFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTV 720
            PF+AFRRVLLQIL C+  TMQHLL+SAS LRKG R S AAA+LHE KFL      Q    
Sbjct: 3053 PFIAFRRVLLQILGCEKCTMQHLLQSASLLRKGTRFSHAAASLHEFKFLCARSNGQQPVP 3112

Query: 721  YWLGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESRSSNSRII 780
             WLG+LEEAKLL AQG+HE++I+LA YI  NY+  EEA D+YR++GKWLAE+RSSNSR I
Sbjct: 3113 DWLGKLEEAKLLHAQGRHEVSISLANYILHNYQLKEEASDIYRVIGKWLAETRSSNSRTI 3172

Query: 781  LENYLKPAVSFSEDQRT-TDKKSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRL 839
            LE YL+PAVS +E+Q +   K+ ++RQ QT FHLAHYADALFKSYEERL+S+EWQAA+RL
Sbjct: 3173 LEKYLRPAVSLAEEQSSKICKRLVDRQSQTWFHLAHYADALFKSYEERLSSSEWQAALRL 3232

Query: 840  RKHKTIELEALIKRLKSSTKGEKTDYSIKIQELQKQLAMDREEAQKLLDDRDNFLGLALE 899
            RKHKT ELE  IKR KSS K E++DYS+KIQ+LQKQL MD+EEA+KL  DRDNFL LALE
Sbjct: 3233 RKHKTKELEVFIKRFKSSKKAEQSDYSLKIQDLQKQLTMDKEEAEKLQVDRDNFLKLALE 3292

Query: 900  GYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDEVQSYKFIPLVYQIASRM 959
            GYKRCL IGDKYDVRVVFR VS+WFSL+S++NVI NM+ TI EVQSYKFIPLVYQIASR+
Sbjct: 3293 GYKRCLEIGDKYDVRVVFRQVSMWFSLASQKNVIDNMLSTIKEVQSYKFIPLVYQIASRL 3352

Query: 960  GSTKDALGLHNFQFALVSLVKKMAIDHPYHTIFQLLALANGDRIKDKQRSRNSFVVDMDK 1019
            GS+KD  G ++FQ ALVSL++KMAIDHPYHTI QLLALANGDRIKD QRSRNSFVVDMDK
Sbjct: 3353 GSSKDESGSNSFQSALVSLIRKMAIDHPYHTILQLLALANGDRIKDNQRSRNSFVVDMDK 3412

Query: 1020 KLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELETRREQDTNKRIQLPREIRCLRQLE 1079
            KLAAE+LL+++S YHG +IRQMKQ+VD+YIKLAELETRRE DTN+++ LPREIR ++QLE
Sbjct: 3413 KLAAEHLLQDVSHYHGPMIRQMKQLVDIYIKLAELETRRE-DTNRKVALPREIRSVKQLE 3471

Query: 1080 LVPVVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKS 1139
            LVPVVTAT+P+D +CQYNEGSFP+F+GL++SV VMNGINAPKVVECFGSDG KY+QLAKS
Sbjct: 3472 LVPVVTATIPVDRSCQYNEGSFPFFRGLSDSVTVMNGINAPKVVECFGSDGQKYKQLAKS 3531

Query: 1140 GNDDLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLG 1199
            GNDDLRQDAVMEQFFGLVNTFL N+RDTWKRRL VRTYKV+PFTPSAG+LEWVDGT+PLG
Sbjct: 3532 GNDDLRQDAVMEQFFGLVNTFLHNNRDTWKRRLAVRTYKVIPFTPSAGVLEWVDGTIPLG 3591

Query: 1200 DYLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFL 1259
            DYLIGS+R+ GAHGRYGIG+W + KCREHMS+ KDKR AF +VC NFRPV+HYFFLE+FL
Sbjct: 3592 DYLIGSSRSEGAHGRYGIGNWKYPKCREHMSSAKDKRKAFVDVCTNFRPVMHYFFLEKFL 3651

Query: 1260 QPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLML 1319
            QPA WF KRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLML
Sbjct: 3652 QPADWFVKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLML 3711

Query: 1320 KTPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKW 1379
            KTPERVPFRLTRDIIDGMG+TGVEGVFRRCCE+TLSVMRTNKEALLTIVEVFIHDPLYKW
Sbjct: 3712 KTPERVPFRLTRDIIDGMGITGVEGVFRRCCEETLSVMRTNKEALLTIVEVFIHDPLYKW 3771

Query: 1380 ALSPLKALQRQKEMDDDLETGLEGPEDEYEGNKDAERALIRVKQKLDGYEGGEMRSVHGQ 1439
            ALSPLKALQRQKE +D     LEG ++E+EGNKDA RAL+RVKQKLDGYEGGEMRS+HGQ
Sbjct: 3772 ALSPLKALQRQKETEDYDGMNLEGLQEEFEGNKDATRALMRVKQKLDGYEGGEMRSIHGQ 3831

Query: 1440 VQQLIQDAIDPERFCLMFPGWGAWL 1464
             QQLIQDAID +R   MFPGWGAW+
Sbjct: 3832 AQQLIQDAIDTDRLSHMFPGWGAWM 3856




Serine/threonine protein kinase which activates checkpoint signaling upon genotoxic stresses such as ionizing radiation (IR) or DNA replication stalling. Plays a central role in the perception and response to both stress-induced damage in somatic cells and developmentally programmed DNA damage during meiosis. Recognizes the substrate consensus sequence [ST]-Q. Phosphorylates histone variant H2AX to form H2AXS139ph at double strand breaks (DSBs), thereby regulating DNA damage response mechanism. Involved in transcriptional regulation of RAD51, PARP1, GR1, and LIG4 in response to DNA double strand breaks. Plays a dual role by activating the DNA damage response at dysfunctional telomeres and yet preventing this activation at functional telomeres. Not required for telomere length homeostasis.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1
>sp|Q62388|ATM_MOUSE Serine-protein kinase ATM OS=Mus musculus GN=Atm PE=1 SV=2 Back     alignment and function description
>sp|Q13315|ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 Back     alignment and function description
>sp|Q6PQD5|ATM_PIG Serine-protein kinase ATM OS=Sus scrofa GN=ATM PE=3 SV=2 Back     alignment and function description
>sp|Q4WVM7|ATM_ASPFU Serine/threonine-protein kinase tel1 OS=Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) GN=tel1 PE=3 SV=2 Back     alignment and function description
>sp|Q4IB89|ATM_GIBZE Serine/threonine-protein kinase TEL1 OS=Gibberella zeae (strain PH-1 / ATCC MYA-4620 / FGSC 9075 / NRRL 31084) GN=TEL1 PE=3 SV=1 Back     alignment and function description
>sp|Q2U639|ATM_ASPOR Serine/threonine-protein kinase tel1 OS=Aspergillus oryzae (strain ATCC 42149 / RIB 40) GN=tel1 PE=3 SV=1 Back     alignment and function description
>sp|O74630|ATM_SCHPO Serine/threonine-protein kinase tel1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=tel1 PE=1 SV=1 Back     alignment and function description
>sp|Q5EAK6|ATM_DROME Serine/threonine-protein kinase ATM OS=Drosophila melanogaster GN=tefu PE=2 SV=1 Back     alignment and function description
>sp|Q5BHE2|ATM_EMENI Serine/threonine-protein kinase tel1 OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) GN=tel1 PE=3 SV=1 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query1464
359491245 2956 PREDICTED: serine/threonine-protein kina 0.982 0.486 0.785 0.0
297733786 3085 unnamed protein product [Vitis vinifera] 0.982 0.466 0.764 0.0
255540663 2954 ataxia telangiectasia mutated, putative 0.984 0.488 0.762 0.0
356507238 3439 PREDICTED: serine/threonine-protein kina 0.983 0.418 0.749 0.0
449441017 2985 PREDICTED: LOW QUALITY PROTEIN: serine/t 0.986 0.483 0.733 0.0
56748564 3856 RecName: Full=Serine/threonine-protein k 0.987 0.375 0.691 0.0
7529272 3856 ataxia-telangiectasia mutated protein (A 0.987 0.375 0.690 0.0
240255538 3845 serine/threonine-protein kinase [Arabido 0.980 0.373 0.687 0.0
297815998 3832 hypothetical protein ARALYDRAFT_323420 [ 0.979 0.374 0.680 0.0
222617585 2743 hypothetical protein OsJ_00056 [Oryza sa 0.961 0.512 0.610 0.0
>gi|359491245|ref|XP_002279402.2| PREDICTED: serine/threonine-protein kinase ATM [Vitis vinifera] Back     alignment and taxonomy information
 Score = 2344 bits (6075), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 1149/1462 (78%), Positives = 1274/1462 (87%), Gaps = 23/1462 (1%)

Query: 7    WHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACR 66
            W +D DIVHAVW LVHMC SDDA+S+RA VSDFISRVGIGDPHCVVFHLP D   +H CR
Sbjct: 1514 WRADQDIVHAVWNLVHMCGSDDANSVRALVSDFISRVGIGDPHCVVFHLPGDYSQIHVCR 1573

Query: 67   PINHGSGSATEFNFHLDAGISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKG 126
            PI+H SG+  E +F LD  ISEELL+A++++LKKYLMDDSV+I+D+TSQTL GILSTE+G
Sbjct: 1574 PIHHDSGA--EISFPLDTSISEELLLALMRLLKKYLMDDSVKIIDLTSQTLWGILSTERG 1631

Query: 127  QRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKFKANGISPEKSTVWETDGKTFET 186
            Q+A++SFDSYERSL+EVHSKGVNVELVE  L DLE+KF A  I  EKST+W+T  KTFE 
Sbjct: 1632 QKALLSFDSYERSLIEVHSKGVNVELVEKLLSDLEKKFNAEAIPLEKSTIWKTHEKTFEM 1691

Query: 187  WICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLISSQ 246
            WICPL +SLIG CND +LRLCQDIVLLK+EVAELLLP+V+VNLAG K++ VDL KLISSQ
Sbjct: 1692 WICPLVHSLIGFCNDTILRLCQDIVLLKAEVAELLLPNVIVNLAGRKDLAVDLCKLISSQ 1751

Query: 247  VQKYIFTESNKLIKSIQVFLNALNELRLCHVMER--SSSVPPKRESSKYVKHSGSSAKPR 304
            VQ+ IF ESN+ IKSIQV L+ALNELRL +VMER  SSS+P KRE+S+    + SS    
Sbjct: 1752 VQENIFVESNRSIKSIQVMLDALNELRLFYVMERTTSSSIPLKRETSRVNSSTMSSVALV 1811

Query: 305  STSAKARDVVATSNATMTTSWDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYK 364
            STS                 W+KVYWLS+DYL VAKSA+ICGSYFTSVMYVEHWCEEH+ 
Sbjct: 1812 STSL----------------WEKVYWLSIDYLDVAKSAIICGSYFTSVMYVEHWCEEHFN 1855

Query: 365  SLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQSHKLSSQIVTLEHEGNWSKA 424
            SLTLG PDFSH E LP HIEILVSA+TQINEPDSLYGIIQ HKL+SQI+T EHEGNWSKA
Sbjct: 1856 SLTLGKPDFSHCEMLPHHIEILVSAITQINEPDSLYGIIQLHKLTSQIITFEHEGNWSKA 1915

Query: 425  LEYYELQVRSDVMLQMDGNSGALSP-HGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVG 483
            LEYY+LQVRS+ +  MDG+S  LSP H   +VH S S SE+ + QR+PYKGL+RSLQ++G
Sbjct: 1916 LEYYDLQVRSEPVAGMDGSSRNLSPEHSQLTVHPSFSKSEDVIRQREPYKGLIRSLQKIG 1975

Query: 484  CMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSG-QNIKSG 542
            C HVLD+YC+GLTS  GQFQHD EFT+LQYEAAWR GNWDFSL Y+GAN PS  Q+I+  
Sbjct: 1976 CTHVLDLYCQGLTSQNGQFQHDLEFTELQYEAAWRAGNWDFSLLYMGANSPSSSQHIRCD 2035

Query: 543  HFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHL 602
            HF+ENLHSCL A +EGD  EF+ KLK SKQELVLSV  AS +STEYIYS I+KLQI  HL
Sbjct: 2036 HFNENLHSCLRAFQEGDFNEFHSKLKDSKQELVLSVCHASGQSTEYIYSTIIKLQIFYHL 2095

Query: 603  GVAWDIRWKSSGESINIYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRTQLHMNLLEPF 662
            G+AW +RW    E I   P  QK+ SEP+IPT+ QLSWLNT+WSSILKRTQLHMNLLEPF
Sbjct: 2096 GMAWGLRWAPPSEKIETSPGMQKVFSEPIIPTMDQLSWLNTDWSSILKRTQLHMNLLEPF 2155

Query: 663  MAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAALHELKFLYTGPGDQCSTVYW 722
            +AFRRVLLQILS KD  +QHLL+S+STLRKG R SQAAAALHE KFL    G+Q S  YW
Sbjct: 2156 IAFRRVLLQILSSKDCMVQHLLQSSSTLRKGSRFSQAAAALHEFKFLCNRMGEQHSASYW 2215

Query: 723  LGRLEEAKLLRAQGQHEMAINLAKYISENYESNEEAPDVYRLVGKWLAESRSSNSRIILE 782
            LGRLEEAKLLRAQGQHEMAINLAKYIS+N + NEEA +VYRLVGKWLAE+RSSNSR ILE
Sbjct: 2216 LGRLEEAKLLRAQGQHEMAINLAKYISQNSQLNEEASNVYRLVGKWLAETRSSNSRTILE 2275

Query: 783  NYLKPAVSFSEDQRTTDKKSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKH 842
             YLK AV  ++D + TDKK+IERQ QTHFHLAHYADALF+S+EERLASNEWQAA RLRKH
Sbjct: 2276 KYLKRAVLLAKDNKNTDKKTIERQSQTHFHLAHYADALFRSHEERLASNEWQAATRLRKH 2335

Query: 843  KTIELEALIKRLKSSTKGEKTDYSIKIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYK 902
            KTIELEALIKRL+SS+KGEKTDYS+KIQELQKQLAMD EEA+KL DDRDNFL L LEGYK
Sbjct: 2336 KTIELEALIKRLRSSSKGEKTDYSVKIQELQKQLAMDAEEAEKLQDDRDNFLSLTLEGYK 2395

Query: 903  RCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTIDEVQSYKFIPLVYQIASRMGST 962
            RCLV+GDKYDVRVVFRLVSLWFSLSSRQNVI  M+ T+ EVQSYKFIPLVYQIASRMGS+
Sbjct: 2396 RCLVLGDKYDVRVVFRLVSLWFSLSSRQNVINMMLSTVQEVQSYKFIPLVYQIASRMGSS 2455

Query: 963  KDALGLHNFQFALVSLVKKMAIDHPYHTIFQLLALANGDRIKDKQRSRNSFVVDMDKKLA 1022
            KD LG H+FQFALVSLVKKM+IDHPYHTIFQLLALANGDRIKDKQRSRNSFVVDMDKKLA
Sbjct: 2456 KDGLGPHSFQFALVSLVKKMSIDHPYHTIFQLLALANGDRIKDKQRSRNSFVVDMDKKLA 2515

Query: 1023 AENLLEELSSYHGAIIRQMKQMVDVYIKLAELETRREQDTNKRIQLPREIRCLRQLELVP 1082
            AENLL+ELSS HG+II+QMKQMV++YIKLAELET+RE DTNKR+ LPREIR LRQLELVP
Sbjct: 2516 AENLLKELSSCHGSIIQQMKQMVEIYIKLAELETKRE-DTNKRVMLPREIRSLRQLELVP 2574

Query: 1083 VVTATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGND 1142
            VVT+T P+D  CQY+EGSFP+FKGL +SVM+MNGINAPKVVEC GSDG KYRQLAKSGND
Sbjct: 2575 VVTSTFPVDRNCQYHEGSFPHFKGLGDSVMIMNGINAPKVVECLGSDGQKYRQLAKSGND 2634

Query: 1143 DLRQDAVMEQFFGLVNTFLRNHRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYL 1202
            DLRQDAVMEQFF LVNTFL NHRDTWKRRL VRTYKVVPFTPSAG+LEWV+GT+PLG+YL
Sbjct: 2635 DLRQDAVMEQFFSLVNTFLENHRDTWKRRLRVRTYKVVPFTPSAGVLEWVNGTLPLGEYL 2694

Query: 1203 IGSTRNGGAHGRYGIGDWSFLKCREHMSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPA 1262
            IGSTRNGGAHGRYG+ DWSF KCREHM+N KDKR AFQEVC+NFRPV+H FFLERFLQPA
Sbjct: 2695 IGSTRNGGAHGRYGMEDWSFSKCREHMTNEKDKRKAFQEVCKNFRPVMHNFFLERFLQPA 2754

Query: 1263 YWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTP 1322
             WFEKRLAYTRSVAASSMVGYIVGLGDRH+MNILIDQATAEVVHIDLGVAFEQGLMLKTP
Sbjct: 2755 DWFEKRLAYTRSVAASSMVGYIVGLGDRHSMNILIDQATAEVVHIDLGVAFEQGLMLKTP 2814

Query: 1323 ERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALS 1382
            ERVPFRLTRDIIDGMGVTGVEGVFRRCCE+TLSVMRTNKEALLTIVEVFIHDPLYKWALS
Sbjct: 2815 ERVPFRLTRDIIDGMGVTGVEGVFRRCCEETLSVMRTNKEALLTIVEVFIHDPLYKWALS 2874

Query: 1383 PLKALQRQKEMDDDLETGLEGPEDEYEGNKDAERALIRVKQKLDGYEGGEMRSVHGQVQQ 1442
            PLKALQRQKE DDDLET LE  E+EYEGNKDA RAL+RVKQKLDGYE GEMRSVHGQV+Q
Sbjct: 2875 PLKALQRQKETDDDLETSLEDLEEEYEGNKDAARALLRVKQKLDGYEEGEMRSVHGQVRQ 2934

Query: 1443 LIQDAIDPERFCLMFPGWGAWL 1464
            LIQDAIDP+RFC MFPGWGAWL
Sbjct: 2935 LIQDAIDPDRFCRMFPGWGAWL 2956




Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Class:

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297733786|emb|CBI15033.3| unnamed protein product [Vitis vinifera] Back     alignment and taxonomy information
>gi|255540663|ref|XP_002511396.1| ataxia telangiectasia mutated, putative [Ricinus communis] gi|223550511|gb|EEF51998.1| ataxia telangiectasia mutated, putative [Ricinus communis] Back     alignment and taxonomy information
>gi|356507238|ref|XP_003522376.1| PREDICTED: serine/threonine-protein kinase ATM-like [Glycine max] Back     alignment and taxonomy information
>gi|449441017|ref|XP_004138280.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase ATM-like [Cucumis sativus] Back     alignment and taxonomy information
>gi|56748564|sp|Q9M3G7.1|ATM_ARATH RecName: Full=Serine/threonine-protein kinase ATM; AltName: Full=Ataxia telangiectasia mutated homolog; Short=AtATM gi|7960715|emb|CAB92122.1| AtATM [Arabidopsis thaliana] Back     alignment and taxonomy information
>gi|7529272|emb|CAB86487.1| ataxia-telangiectasia mutated protein (Atm) [Arabidopsis thaliana] Back     alignment and taxonomy information
>gi|240255538|ref|NP_190402.6| serine/threonine-protein kinase [Arabidopsis thaliana] gi|332644858|gb|AEE78379.1| serine/threonine-protein kinase [Arabidopsis thaliana] Back     alignment and taxonomy information
>gi|297815998|ref|XP_002875882.1| hypothetical protein ARALYDRAFT_323420 [Arabidopsis lyrata subsp. lyrata] gi|297321720|gb|EFH52141.1| hypothetical protein ARALYDRAFT_323420 [Arabidopsis lyrata subsp. lyrata] Back     alignment and taxonomy information
>gi|222617585|gb|EEE53717.1| hypothetical protein OsJ_00056 [Oryza sativa Japonica Group] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query1464
MGI|MGI:1072023066 Atm "ataxia telangiectasia mut 0.650 0.310 0.373 8.6e-177
ZFIN|ZDB-GENE-040809-12773 atm "ataxia telangiectasia mut 0.648 0.342 0.368 4.8e-174
UNIPROTKB|Q5MPF83061 atm "Ataxia telangiectasia mut 0.648 0.310 0.378 1.7e-173
UNIPROTKB|Q133153056 ATM "Serine-protein kinase ATM 0.648 0.310 0.375 5e-173
RGD|15932653064 Atm "ataxia telangiectasia mut 0.648 0.310 0.375 5.4e-170
UNIPROTKB|Q6PQD53057 ATM "Serine-protein kinase ATM 0.648 0.310 0.362 1.6e-168
UNIPROTKB|J9JHR53057 ATM "Uncharacterized protein" 0.648 0.310 0.369 3.3e-168
UNIPROTKB|E1BEI63057 ATM "Uncharacterized protein" 0.650 0.311 0.374 3.6e-168
UNIPROTKB|E1C0Q63069 ATM "Uncharacterized protein" 0.797 0.380 0.335 6.2e-162
UNIPROTKB|F1PEL73065 ATM "Uncharacterized protein" 0.623 0.297 0.359 3e-159
MGI|MGI:107202 Atm "ataxia telangiectasia mutated homolog (human)" [Mus musculus (taxid:10090)] Back     alignment and assigned GO terms
 Score = 1557 (553.2 bits), Expect = 8.6e-177, Sum P(3) = 8.6e-177
 Identities = 387/1036 (37%), Positives = 582/1036 (56%)

Query:   474 GLMRSLQQVGCMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANF 533
             G++++LQ +G  H+L +Y KGL   + ++    E  +L+Y+AAWR   W       G   
Sbjct:  2069 GIIQALQNLGLSHILSVYLKGLDYERREWC--AELQELRYQAAWRNMQW-------GLCA 2119

Query:   534 PSGQNIKSGHFHENLHSCLTALREGDSEEFYRKLKHSKQELVLSVACASEESTEYIYSAI 593
              +GQ ++   +HE+L++ L  LR  +   FY  L+++    V  V   S+ S E +YS  
Sbjct:  2120 SAGQEVEGTSYHESLYNALQCLRNREFSTFYESLRYASLFRVKEVEELSKGSLESVYSLY 2179

Query:   594 VKLQILCHLGVAWDIRWKSSGESIN-IYPEKQKIVSEPVIPTVGQLSWLNTEWSSILKRT 652
               L  L  +G       ++SGE  +    ++++  +        QL   ++++S      
Sbjct:  2180 PTLSRLQAIG-----ELENSGELFSRSVTDRERSEAYWKWQKHSQLL-KDSDFSFQEPLM 2233

Query:   653 QLHMNLLEPFMAFRRVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAA-ALHELKFLYT 711
              L   +LE  +       Q    KD   +HL+E  S L + F+ +Q    A+ ++K  Y 
Sbjct:  2234 ALRTVILETLVQKEMERSQGACSKDILTKHLVEF-SVLARTFKNTQLPERAIFKIK-QYN 2291

Query:   712 GPGDQCSTVYWLGRLEEAKLLRAQGQHEMAINLAKYISENYESN--EEAPD-----VY-- 762
                  C    W   LEEA++  A+ +  +A+++ K + +  +S+  ++  D     +Y  
Sbjct:  2292 SA--ICGISEW--HLEEAQVFWAKKEQSLALSILKQMIKKLDSSFKDKENDAGLKVIYAE 2347

Query:   763 --RLVGKWLAESRSSNSRIILENYLKPAVSFSEDQRTTDKKSIERQCQTHFHLAHYADAL 820
               R+ G WLAE+   N  +I++ YL+ AV  +       ++    Q +    LA ++D  
Sbjct:  2348 CLRVCGSWLAETCLENPAVIMQTYLEKAVKVAGSYDGNSRELRNGQMKAFLSLARFSDTQ 2407

Query:   821 FKSYEERLASNEWQAAMRLRKHKTIELEALIKRLKSSTKGEKTDYSIKIQELQKQLAMDR 880
             ++  E  + S+E++    L K    E+  L++  K  T      Y++K+Q   ++L +D 
Sbjct:  2408 YQRIENYMKSSEFENKQTLLKRAKEEV-GLLREHKIQTNR----YTVKVQ---RELELDE 2459

Query:   881 EEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVIKNMVDTI 940
                + L +DR  FL  A+E Y  CL+ G+++D+ V FRL SLW   S    V   M    
Sbjct:  2460 CALRALREDRKRFLCKAVENYINCLLSGEEHDLWV-FRLCSLWLENSGVSEVNGMMKKDG 2518

Query:   941 DEVQSYKFIPLVYQIASRMGSTKDALGLHNFQFALVSLVKKMAIDHPYHTIFQLLALANG 1000
              ++ SYKF+PL+YQ+A+RMG TK   GL  F   L +L+ ++++DHP+HT+F +LALAN 
Sbjct:  2519 MKISSYKFLPLMYQLAARMG-TKMTGGL-GFHEVLNNLISRISLDHPHHTLFIILALANA 2576

Query:  1001 --DRIKDK----QRSR--------NSFVVDMDKKXXXXXXXXXXSSYHGAIIRQMKQMVD 1046
               D    K    +RSR        NS + D D+            S    +++ M+ + D
Sbjct:  2577 NKDEFLSKPETTRRSRITKSTSKENSHL-DEDRTEAATRIIHSIRSKRCKMVKDMEALCD 2635

Query:  1047 VYIKLAELETRREQDTNKRIQLP--REIRCLRQLELVPVVTATVPIDCTCQYNEGSFPYF 1104
              YI LA ++  + +   K I +P  + I  L+ LE V V T  + +D T +Y   +    
Sbjct:  2636 AYIILANMDASQWRAQRKGINIPANQPITKLKNLEDVVVPTMEIKVDPTGEYE--NLVTI 2693

Query:  1105 KGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNH 1164
             K       +  G+N PK+++C GSDG + RQL K G DDLRQDAVM+Q F + NT L+ +
Sbjct:  2694 KSFKTEFRLAGGLNLPKIIDCVGSDGKERRQLVK-GRDDLRQDAVMQQVFQMCNTLLQRN 2752

Query:  1165 RDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLK 1224
              +T KR+L + TYKVVP +  +G+LEW  GTVP+G+YL+ S    GAH RY   D+S  +
Sbjct:  2753 TETRKRKLTICTYKVVPLSQRSGVLEWCTGTVPIGEYLVNS--EDGAHRRYRPNDFSANQ 2810

Query:  1225 CREHMSNVKDKRI-----AFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASS 1279
             C++ M  V+ K        F  +C+NF PV  YF +E+FL PA WFEKRLAYTRSVA SS
Sbjct:  2811 CQKKMMEVQKKSFEEKYDTFMTICQNFEPVFRYFCMEKFLDPAVWFEKRLAYTRSVATSS 2870

Query:  1280 MVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGV 1339
             +VGYI+GLGDRH  NILI++ +AE+VHIDLGVAFEQG +L TPE VPFRL+RDI+DGMG+
Sbjct:  2871 IVGYILGLGDRHVQNILINEQSAELVHIDLGVAFEQGKILPTPETVPFRLSRDIVDGMGI 2930

Query:  1340 TGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKAL--QRQKEMDDDL 1397
             TGVEGVFRRCCEKT+ VMR+++E LLTIVEV ++DPL+ W ++PLKAL  Q++ E + DL
Sbjct:  2931 TGVEGVFRRCCEKTMEVMRSSQETLLTIVEVLLYDPLFDWTMNPLKALYLQQRPEDESDL 2990

Query:  1398 ETGLEGPEDEYEG---------NKDAERALIRVKQKLDGYEGGEMRSVHGQVQQLIQDAI 1448
              +     + E +          NK AER L+R+++KL G E G + SV GQV  LIQ A+
Sbjct:  2991 HSTPNADDQECKQSLSDTDQSFNKVAERVLMRLQEKLKGVEEGTVLSVGGQVNLLIQQAM 3050

Query:  1449 DPERFCLMFPGWGAWL 1464
             DP+    +FPGW AW+
Sbjct:  3051 DPKNLSRLFPGWKAWV 3066


GO:0000077 "DNA damage checkpoint" evidence=IMP
GO:0000166 "nucleotide binding" evidence=IEA
GO:0000723 "telomere maintenance" evidence=IEA
GO:0001666 "response to hypoxia" evidence=ISO
GO:0001756 "somitogenesis" evidence=IGI
GO:0002331 "pre-B cell allelic exclusion" evidence=IMP
GO:0003677 "DNA binding" evidence=IEA
GO:0004672 "protein kinase activity" evidence=IDA;TAS
GO:0004674 "protein serine/threonine kinase activity" evidence=ISO
GO:0004677 "DNA-dependent protein kinase activity" evidence=ISO
GO:0005515 "protein binding" evidence=IPI
GO:0005524 "ATP binding" evidence=IEA
GO:0005634 "nucleus" evidence=ISO;TAS
GO:0005737 "cytoplasm" evidence=ISO
GO:0005819 "spindle" evidence=IDA
GO:0006281 "DNA repair" evidence=IDA;IMP
GO:0006468 "protein phosphorylation" evidence=IDA;TAS
GO:0006974 "response to DNA damage stimulus" evidence=ISO;TAS
GO:0006975 "DNA damage induced protein phosphorylation" evidence=ISO
GO:0007049 "cell cycle" evidence=IEA
GO:0007050 "cell cycle arrest" evidence=ISO
GO:0007094 "mitotic spindle assembly checkpoint" evidence=ISO
GO:0007292 "female gamete generation" evidence=IMP
GO:0007420 "brain development" evidence=IGI
GO:0007507 "heart development" evidence=IGI
GO:0008630 "intrinsic apoptotic signaling pathway in response to DNA damage" evidence=IGI;IMP
GO:0010212 "response to ionizing radiation" evidence=ISO;IGI
GO:0016301 "kinase activity" evidence=IEA
GO:0016303 "1-phosphatidylinositol-3-kinase activity" evidence=ISO
GO:0016310 "phosphorylation" evidence=IEA
GO:0016572 "histone phosphorylation" evidence=ISO
GO:0016740 "transferase activity" evidence=IEA
GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA
GO:0016773 "phosphotransferase activity, alcohol group as acceptor" evidence=IEA
GO:0018105 "peptidyl-serine phosphorylation" evidence=ISO
GO:0030889 "negative regulation of B cell proliferation" evidence=ISO
GO:0031410 "cytoplasmic vesicle" evidence=IEA
GO:0031572 "G2 DNA damage checkpoint" evidence=ISO
GO:0032403 "protein complex binding" evidence=ISO
GO:0035174 "histone serine kinase activity" evidence=ISO
GO:0035404 "histone-serine phosphorylation" evidence=ISO
GO:0036092 "phosphatidylinositol-3-phosphate biosynthetic process" evidence=ISO
GO:0042159 "lipoprotein catabolic process" evidence=IGI
GO:0043065 "positive regulation of apoptotic process" evidence=ISO
GO:0043066 "negative regulation of apoptotic process" evidence=IMP
GO:0043517 "positive regulation of DNA damage response, signal transduction by p53 class mediator" evidence=ISO
GO:0043525 "positive regulation of neuron apoptotic process" evidence=IGI
GO:0046777 "protein autophosphorylation" evidence=ISO
GO:0046983 "protein dimerization activity" evidence=ISO
GO:0047485 "protein N-terminus binding" evidence=ISO
GO:0051402 "neuron apoptotic process" evidence=IGI
GO:0051726 "regulation of cell cycle" evidence=ISO
GO:0071044 "histone mRNA catabolic process" evidence=ISO
GO:0071480 "cellular response to gamma radiation" evidence=ISO
GO:0090399 "replicative senescence" evidence=ISO
ZFIN|ZDB-GENE-040809-1 atm "ataxia telangiectasia mutated" [Danio rerio (taxid:7955)] Back     alignment and assigned GO terms
UNIPROTKB|Q5MPF8 atm "Ataxia telangiectasia mutated" [Xenopus laevis (taxid:8355)] Back     alignment and assigned GO terms
UNIPROTKB|Q13315 ATM "Serine-protein kinase ATM" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
RGD|1593265 Atm "ataxia telangiectasia mutated" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms
UNIPROTKB|Q6PQD5 ATM "Serine-protein kinase ATM" [Sus scrofa (taxid:9823)] Back     alignment and assigned GO terms
UNIPROTKB|J9JHR5 ATM "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] Back     alignment and assigned GO terms
UNIPROTKB|E1BEI6 ATM "Uncharacterized protein" [Bos taurus (taxid:9913)] Back     alignment and assigned GO terms
UNIPROTKB|E1C0Q6 ATM "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
UNIPROTKB|F1PEL7 ATM "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server ?

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software ?

Prediction LevelEC numberConfidence of Prediction
4th Layer2.7.11.10.737
3rd Layer2.7.110.691

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING ?

Your Input:
ATM
ATM (ATAXIA-TELANGIECTASIA MUTATED); 1-phosphatidylinositol-3-phosphate 5-kinase; encodes a homolog of the human ATM gene, which is mutated in ataxia telangiectasia, a chromosome instability disorder. Characterization of mutants suggest a role in repairing DNA in response to ionizing radiation as well as during meiosis. The protein has kinase domains and shows kinase activity in orthologs. There is also evidence that ATM might be involved in the telomerase-independent process known as Alternative Lengthening of Telomeres. ; Serine/threonine protein kinase which activates checkpoint sig [...] (3845 aa)
(Arabidopsis thaliana)
Predicted Functional Partners:
BRCA1
ATBRCA1; ubiquitin-protein ligase; Encodes AtBRCA1, an ortholog of the human breast cancer susc [...] (941 aa)
       0.871
H2AXA
H2AXA; DNA binding; Variant histone H2A which replaces conventional H2A in a subset of nucleoso [...] (142 aa)
       0.867
RAD50
RAD50; ATP binding / nuclease/ zinc ion binding; RAD50; FUNCTIONS IN- zinc ion binding, ATP bin [...] (1316 aa)
      0.847
GAMMA-H2AX
GAMMA-H2AX (GAMMA HISTONE VARIANT H2AX); DNA binding; Variant histone H2A which replaces conven [...] (142 aa)
       0.821
ATRAD51
ATRAD51; ATP binding / DNA binding / DNA-dependent ATPase/ damaged DNA binding / nucleoside-tri [...] (342 aa)
       0.788
MRE11
MRE11 (meiotic recombination 11); endonuclease/ exonuclease/ hydrolase/ manganese ion binding / [...] (720 aa)
       0.786
PARP2
PARP2 (POLY(ADP-RIBOSE) POLYMERASE 2); DNA binding / NAD or NADH binding / NAD+ ADP-ribosyltran [...] (983 aa)
       0.748
ERCC1
ERCC1; 5'-flap endonuclease; encodes a homolog of human ERCC1 protein (yeast RAD10), which is a [...] (410 aa)
       0.677
APP
APP (ARABIDOPSIS POLY(ADP-RIBOSE) POLYMERASE); NAD+ ADP-ribosyltransferase/ nucleic acid bindin [...] (637 aa)
       0.677
WEE1
WEE1 (ARABIDOPSIS WEE1 KINASE HOMOLOG); kinase/ protein kinase; Protein kinase that negatively [...] (500 aa)
       0.659

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query1464
cd05171279 cd05171, PIKKc_ATM, Ataxia telangiectasia mutated 1e-172
cd00892237 cd00892, PIKKc_ATR, ATR (Ataxia telangiectasia and 1e-88
cd05164222 cd05164, PIKKc, Phosphoinositide 3-kinase-related 1e-82
cd05169280 cd05169, PIKKc_TOR, TOR (Target of rapamycin), cat 3e-75
COG50322105 COG5032, TEL1, Phosphatidylinositol kinase and pro 2e-74
smart00146240 smart00146, PI3Kc, Phosphoinositide 3-kinase, cata 2e-67
cd00142219 cd00142, PI3Kc_like, Phosphoinositide 3-kinase (PI 2e-60
pfam00454233 pfam00454, PI3_PI4_kinase, Phosphatidylinositol 3- 5e-53
cd05172235 cd05172, PIKKc_DNA-PK, DNA-dependent protein kinas 7e-53
cd05170307 cd05170, PIKKc_SMG1, Suppressor of morphogenetic e 1e-45
cd00896350 cd00896, PI3Kc_III, Phosphoinositide 3-kinase (PI3 3e-13
pfam02259350 pfam02259, FAT, FAT domain 8e-13
cd05167311 cd05167, PI4Kc_III_alpha, Phosphoinositide 4-kinas 1e-12
cd05168293 cd05168, PI4Kc_III_beta, Phosphoinositide 4-kinase 2e-12
cd05170307 cd05170, PIKKc_SMG1, Suppressor of morphogenetic e 3e-12
cd00891352 cd00891, PI3Kc, Phosphoinositide 3-kinase (PI3K), 6e-12
cd00893289 cd00893, PI4Kc_III, Phosphoinositide 4-kinase (PI4 1e-11
cd05163253 cd05163, TRRAP, TRansformation/tRanscription domai 1e-11
cd05173362 cd05173, PI3Kc_IA_beta, Phosphoinositide 3-kinase 3e-11
pfam0226033 pfam02260, FATC, FATC domain 6e-09
cd05165366 cd05165, PI3Kc_I, Phosphoinositide 3-kinase (PI3K) 1e-08
cd05174361 cd05174, PI3Kc_IA_delta, Phosphoinositide 3-kinase 2e-06
cd00894365 cd00894, PI3Kc_IB_gamma, Phosphoinositide 3-kinase 9e-06
cd05166353 cd05166, PI3Kc_II, Phosphoinositide 3-kinase (PI3K 6e-05
cd05175366 cd05175, PI3Kc_IA_alpha, Phosphoinositide 3-kinase 5e-04
>gnl|CDD|119431 cd05171, PIKKc_ATM, Ataxia telangiectasia mutated (ATM), catalytic domain; The ATM catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
 Score =  516 bits (1331), Expect = e-172
 Identities = 181/283 (63%), Positives = 221/283 (78%), Gaps = 9/283 (3%)

Query: 1104 FKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRN 1163
                 +      GINAPK++ C GSDG KY+QL K G+DD RQDAVMEQ F LVNT L  
Sbjct: 1    VSKFKDVFTTAGGINAPKIITCVGSDGKKYKQLLKGGDDD-RQDAVMEQVFQLVNTLLER 59

Query: 1164 HRDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFL 1223
            +++T KR+L +RTYKVVP +P AGILEWVDGT+PLG+YL+G+T   GAH RY  GDW+  
Sbjct: 60   NKETRKRKLRIRTYKVVPLSPRAGILEWVDGTIPLGEYLVGAT---GAHERYRPGDWTAR 116

Query: 1224 KCREHMSNVK-----DKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAAS 1278
            KCR+ M+ V+     ++   F ++C+NFRPV  YFFLE+FL P  WFE+RLAYTRSVA S
Sbjct: 117  KCRKAMAEVQKESNEERLKVFLKICKNFRPVFRYFFLEKFLDPQDWFERRLAYTRSVATS 176

Query: 1279 SMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMG 1338
            S+VGYI+GLGDRHA NILID+ TAEVVHIDLG+AFEQG +L  PE VPFRLTRDI+DGMG
Sbjct: 177  SIVGYILGLGDRHANNILIDEKTAEVVHIDLGIAFEQGKILPVPETVPFRLTRDIVDGMG 236

Query: 1339 VTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWAL 1381
            +TGVEGVFRRCCEKTL V+R NK+A+LTI+EV ++DPLY W +
Sbjct: 237  ITGVEGVFRRCCEKTLEVLRDNKDAILTILEVLLYDPLYSWTV 279


ATM is a member of the phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily. PIKKs have intrinsic serine/threonine kinase activity and are distinguished from other PKs by their unique catalytic domain, similar to that of lipid PI3K, and their large molecular weight (240-470 kDa). ATM contains a FAT (FRAP, ATM and TRRAP) domain, a catalytic domain, and a FATC domain at the C-terminus. ATM is critical in the response to DNA double strand breaks (DSBs) caused by radiation. It is activated at the site of a DSB and phosphorylates key substrates that trigger pathways that regulate DNA repair and cell cycle checkpoints at the G1/S, S phase, and G2/M transition. Patients with the human genetic disorder Ataxia telangiectasia (A-T), caused by truncating mutations in ATM, show genome instability, increased cancer risk, immunodeficiency, compromised mobility, and neurodegeneration. A-T displays clinical heterogeneity, which is correlated to the degree of retained ATM activity. Length = 279

>gnl|CDD|119418 cd00892, PIKKc_ATR, ATR (Ataxia telangiectasia and Rad3-related), catalytic domain; The ATR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119424 cd05164, PIKKc, Phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily, catalytic domain; The PIKK catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119429 cd05169, PIKKc_TOR, TOR (Target of rapamycin), catalytic domain; The TOR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|227365 COG5032, TEL1, Phosphatidylinositol kinase and protein kinases of the PI-3 kinase family [Signal transduction mechanisms / Cell division and chromosome partitioning / Chromatin structure and dynamics / DNA replication, recombination, and repair / Intracellular trafficking and secretion] Back     alignment and domain information
>gnl|CDD|214538 smart00146, PI3Kc, Phosphoinositide 3-kinase, catalytic domain Back     alignment and domain information
>gnl|CDD|119416 cd00142, PI3Kc_like, Phosphoinositide 3-kinase (PI3K)-like family, catalytic domain; The PI3K-like catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|189554 pfam00454, PI3_PI4_kinase, Phosphatidylinositol 3- and 4-kinase Back     alignment and domain information
>gnl|CDD|119432 cd05172, PIKKc_DNA-PK, DNA-dependent protein kinase (DNA-PK), catalytic domain; The DNA-PK catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119430 cd05170, PIKKc_SMG1, Suppressor of morphogenetic effect on genitalia-1 (SMG-1), catalytic domain; The SMG-1 catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119422 cd00896, PI3Kc_III, Phosphoinositide 3-kinase (PI3K), class III, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|216950 pfam02259, FAT, FAT domain Back     alignment and domain information
>gnl|CDD|119427 cd05167, PI4Kc_III_alpha, Phosphoinositide 4-kinase (PI4K), Type III, alpha isoform, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119428 cd05168, PI4Kc_III_beta, Phosphoinositide 4-kinase (PI4K), Type III, beta isoform, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119430 cd05170, PIKKc_SMG1, Suppressor of morphogenetic effect on genitalia-1 (SMG-1), catalytic domain; The SMG-1 catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119417 cd00891, PI3Kc, Phosphoinositide 3-kinase (PI3K), catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119419 cd00893, PI4Kc_III, Phosphoinositide 4-kinase (PI4K), Type III, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119423 cd05163, TRRAP, TRansformation/tRanscription domain-Associated Protein (TRRAP), pseudokinase domain; The TRRAP catalytic domain is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119433 cd05173, PI3Kc_IA_beta, Phosphoinositide 3-kinase (PI3K), class IA, beta isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|202180 pfam02260, FATC, FATC domain Back     alignment and domain information
>gnl|CDD|119425 cd05165, PI3Kc_I, Phosphoinositide 3-kinase (PI3K), class I, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119434 cd05174, PI3Kc_IA_delta, Phosphoinositide 3-kinase (PI3K), class IA, delta isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119420 cd00894, PI3Kc_IB_gamma, Phosphoinositide 3-kinase (PI3K), class IB, gamma isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|119426 cd05166, PI3Kc_II, Phosphoinositide 3-kinase (PI3K), class II, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>gnl|CDD|88554 cd05175, PI3Kc_IA_alpha, Phosphoinositide 3-kinase (PI3K), class IA, alpha isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 1464
KOG08922806 consensus Protein kinase ATM/Tel1, involved in tel 100.0
KOG08902382 consensus Protein kinase of the PI-3 kinase family 100.0
KOG08912341 consensus DNA-dependent protein kinase [Replicatio 100.0
COG50322105 TEL1 Phosphatidylinositol kinase and protein kinas 100.0
KOG08893550 consensus Histone acetyltransferase SAGA, TRRAP/TR 100.0
cd05171279 PIKKc_ATM Ataxia telangiectasia mutated (ATM), cat 100.0
cd05170307 PIKKc_SMG1 Suppressor of morphogenetic effect on g 100.0
cd05163253 TRRAP TRansformation/tRanscription domain-Associat 100.0
cd05169280 PIKKc_TOR TOR (Target of rapamycin), catalytic dom 100.0
cd05172235 PIKKc_DNA-PK DNA-dependent protein kinase (DNA-PK) 100.0
cd00892237 PIKKc_ATR ATR (Ataxia telangiectasia and Rad3-rela 100.0
cd05164222 PIKKc Phosphoinositide 3-kinase-related protein ki 100.0
cd00142219 PI3Kc_like Phosphoinositide 3-kinase (PI3K)-like f 100.0
cd00891352 PI3Kc Phosphoinositide 3-kinase (PI3K), catalytic 100.0
cd00896350 PI3Kc_III Phosphoinositide 3-kinase (PI3K), class 100.0
cd05166353 PI3Kc_II Phosphoinositide 3-kinase (PI3K), class I 100.0
cd05165366 PI3Kc_I Phosphoinositide 3-kinase (PI3K), class I, 100.0
cd05168293 PI4Kc_III_beta Phosphoinositide 4-kinase (PI4K), T 100.0
cd05177354 PI3Kc_C2_gamma Phosphoinositide 3-kinase (PI3K), c 100.0
smart00146202 PI3Kc Phosphoinositide 3-kinase, catalytic domain. 100.0
cd00894365 PI3Kc_IB_gamma Phosphoinositide 3-kinase (PI3K), c 100.0
cd05174361 PI3Kc_IA_delta Phosphoinositide 3-kinase (PI3K), c 100.0
cd00893289 PI4Kc_III Phosphoinositide 4-kinase (PI4K), Type I 100.0
cd05176353 PI3Kc_C2_alpha Phosphoinositide 3-kinase (PI3K), c 100.0
cd05173362 PI3Kc_IA_beta Phosphoinositide 3-kinase (PI3K), cl 100.0
PF00454235 PI3_PI4_kinase: Phosphatidylinositol 3- and 4-kina 100.0
cd05167311 PI4Kc_III_alpha Phosphoinositide 4-kinase (PI4K), 100.0
cd00895354 PI3Kc_C2_beta Phosphoinositide 3-kinase (PI3K), cl 100.0
cd05175366 PI3Kc_IA_alpha Phosphoinositide 3-kinase (PI3K), c 100.0
KOG0905 1639 consensus Phosphoinositide 3-kinase [Signal transd 100.0
KOG0906843 consensus Phosphatidylinositol 3-kinase VPS34, inv 100.0
PF02259352 FAT: FAT domain; InterPro: IPR003151 The FAT domai 100.0
KOG09041076 consensus Phosphatidylinositol 3-kinase catalytic 100.0
KOG09021803 consensus Phosphatidylinositol 4-kinase [Signal tr 99.96
KOG0903847 consensus Phosphatidylinositol 4-kinase, involved 99.93
PTZ003031374 phosphatidylinositol kinase; Provisional 99.9
PF0226033 FATC: FATC domain; InterPro: IPR003152 The FATC do 99.33
KOG0892 2806 consensus Protein kinase ATM/Tel1, involved in tel 98.85
TIGR02917899 PEP_TPR_lipo putative PEP-CTERM system TPR-repeat 95.63
smart00145184 PI3Ka Phosphoinositide 3-kinase family, accessory 93.42
TIGR02917899 PEP_TPR_lipo putative PEP-CTERM system TPR-repeat 92.43
cd00870166 PI3Ka_III Phosphoinositide 3-kinase (PI3K) class I 92.31
cd00872171 PI3Ka_I Phosphoinositide 3-kinase (PI3K) class I, 92.15
PLN032181060 maturation of RBCL 1; Provisional 90.71
cd00864152 PI3Ka Phosphoinositide 3-kinase family, accessory 90.29
PLN03081697 pentatricopeptide (PPR) repeat-containing protein; 89.39
PRK10747398 putative protoheme IX biogenesis protein; Provisio 87.31
PF00613184 PI3Ka: Phosphoinositide 3-kinase family, accessory 86.96
PRK15174656 Vi polysaccharide export protein VexE; Provisional 86.66
cd00869169 PI3Ka_II Phosphoinositide 3-kinase (PI3K) class II 86.57
PLN032181060 maturation of RBCL 1; Provisional 85.76
PRK114471157 cellulose synthase subunit BcsC; Provisional 82.73
>KOG0892 consensus Protein kinase ATM/Tel1, involved in telomere length regulation and DNA repair [Signal transduction mechanisms; Chromatin structure and dynamics; Replication, recombination and repair; Cell cycle control, cell division, chromosome partitioning] Back     alignment and domain information
Probab=100.00  E-value=1e-174  Score=1682.78  Aligned_cols=1251  Identities=40%  Similarity=0.595  Sum_probs=1007.5

Q ss_pred             cccCCChhHHHHHHHHHHhhcCCCcccHHHHHHHHHhhhCCCCCcEEEEecCCCccccccccCCCCCCCCCccceeccCc
Q 000483            5 VDWHSDHDIVHAVWTLVHMCCSDDASSIRAWVSDFISRVGIGDPHCVVFHLPRDSIYMHACRPINHGSGSATEFNFHLDA   84 (1464)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (1464)
                      .+|+.+++++..+|..+++-....+-+.....-+|+.+++..|+|.++|++|+..+++|+-.-..+.  .+.-+.-.+-.
T Consensus      1510 ~~~q~~~e~v~~~~~~~q~~~~~~~~~~~e~~~~~~~~v~~~~~~~L~~~~~~~~~~s~g~~i~~~~--~~~n~~~~~K~ 1587 (2806)
T KOG0892|consen 1510 WFWQKSPEIVDLVHYYPQTDPRLCDTSNYEPSKDFLWKVICQDDCSLLFKLPILLDSSIGIQIRMFF--EGSNIMELTKN 1587 (2806)
T ss_pred             hHHhcCccceechhhcccCChhhhhhcccCchhhhhhchhccccceEEEEcCcccccchhhhhhhcc--ccchhhhhhhh
Confidence            4799999999999999999999999999999999999999999999999999998877754432222  23334444556


Q ss_pred             cchHHHHHHHHHHHHHhhhcCcchhhchHHHHHHHHhccccccchhhchhHHHHHHHHhhhccCcchhhHhhhhhhhhhh
Q 000483           85 GISEELLIAVLKILKKYLMDDSVQIVDMTSQTLRGILSTEKGQRAVMSFDSYERSLLEVHSKGVNVELVETFLLDLERKF  164 (1464)
Q Consensus        85 ~~~~~~~~~il~~l~~~l~~~~~~~~~~a~~~L~~ils~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (1464)
                      ++.++........+..+..+..+.+.....++....+++-.+......++.|.+.+++++                    
T Consensus      1588 ~i~~~dk~~~~~~~~~~~~~~~~~~~~il~~t~~es~s~w~s~~~ls~f~~c~~~~~~~~-------------------- 1647 (2806)
T KOG0892|consen 1588 LIFPLDKITLDSFLKTLVSEEGSFIIDILQQTNNESLSNWLSEFALKLFNMCGRSSTTHS-------------------- 1647 (2806)
T ss_pred             hccchhHHHHHHHHHHHhhccchhHHHHHhhhhccchhhHHHHHHHHHHHHHhccCCchh--------------------
Confidence            788888888889999999999999999999999999999888888777888877776632                    


Q ss_pred             hcCCCCCCCCCccccCCCCHHhhHHHHHHHhhccCCchhhhhcHHHHhccHhHHHHHhHHHHHHHhcCCCcchhHHHHHH
Q 000483          165 KANGISPEKSTVWETDGKTFETWICPLTYSLIGCCNDVVLRLCQDIVLLKSEVAELLLPSVVVNLAGSKNVDVDLQKLIS  244 (1464)
Q Consensus       165 ~~~~~~~~~~~~w~~~~~s~~~Wi~~l~~~Ll~~~~~~~L~~~~~l~~~~~~~A~~LlP~~v~~i~~~~d~~~~~~~~ls  244 (1464)
                                  |.++......|++.++..+|-.+.+..   |..+....--+-+.++|.+..+                
T Consensus      1648 ------------~st~~~~~~t~i~~~i~~~l~~~s~~~---~~~~~~~~~yi~~~~~~sl~~n---------------- 1696 (2806)
T KOG0892|consen 1648 ------------LSTYMANFSTSICQLIICLLLLESDFN---PGNNLKQKDYIFELILSSLLKN---------------- 1696 (2806)
T ss_pred             ------------hccccccccHHHHHHHHHHHHhhcccc---HHHHHHHHHHHHHHHhhccccc----------------
Confidence                        444555578899999988874333222   4444444444444444443211                


Q ss_pred             HHHHhhhhhccchhhHHHHHHHHHHHHHhHhhHhhhccCCCCCcccccccccCCCCCCCccchhhhhhhhhhcccccccc
Q 000483          245 SQVQKYIFTESNKLIKSIQVFLNALNELRLCHVMERSSSVPPKRESSKYVKHSGSSAKPRSTSAKARDVVATSNATMTTS  324 (1464)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~q~~l~~~~~Lr~~~~~e~~~~~p~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~  324 (1464)
                                   .-....+-+|.+.++|.+   ++-.+                                      -+.
T Consensus      1697 -------------~~~~~~m~~ni~~~~~~~---~~~~~--------------------------------------~n~ 1722 (2806)
T KOG0892|consen 1697 -------------SNSIFKMDMNILKYLRRQ---LGCHA--------------------------------------FNP 1722 (2806)
T ss_pred             -------------hhHHHHHHHHHHHHHHHh---hchhh--------------------------------------hcc
Confidence                         011233345666666654   11100                                      013


Q ss_pred             cccccccccCHHHHHHHHHHhchhhHHHHhhHhHHHHhhccccCCCCCCCccCCcchHHHHHHHHHhhCCCchhhhhhhc
Q 000483          325 WDKVYWLSVDYLRVAKSAVICGSYFTSVMYVEHWCEEHYKSLTLGSPDFSHLETLPRHIEILVSAVTQINEPDSLYGIIQ  404 (1464)
Q Consensus       325 ~~~~~wL~Id~~~lA~aA~~C~ay~tALly~E~~~~~~~~~~~~~~~~~s~~~~~~~~~e~L~~IY~~IdEPD~~yGi~~  404 (1464)
                      |....|+++++...+-++.+|.+|-..++|.=+.-.+          ..+........+|+|.++|+.|++||++||+..
T Consensus      1723 ~~~~~~~~~~~~~~~~~~~~~~~~e~s~~~~t~~~~k----------~k~~e~~~~~lqDil~~~y~~I~~pD~lyG~~~ 1792 (2806)
T KOG0892|consen 1723 FEIYYWLPIVYSVAASTAYDCLLFEYSLLSLTIHSPK----------NKRDELDITLLQDILKKAYESINCPDALYGIKR 1792 (2806)
T ss_pred             hhhhccccHHHHHHHHHHHHHHHHHHHHHHHhhcCcc----------cchhHHHHHHHHHHHHHHHhhCCCcchhcccCC
Confidence            4455689999999999999998888888776541100          111122334456778888999999999999998


Q ss_pred             ccchh-hHHHHHHhhCCHHHHHHHHHHHHhhhhhcccCCCCCCCCCCCCCccCCCCCchhhhhhccchhhHHHHHHHhhc
Q 000483          405 SHKLS-SQIVTLEHEGNWSKALEYYELQVRSDVMLQMDGNSGALSPHGLPSVHLSPSTSENEMMQRKPYKGLMRSLQQVG  483 (1464)
Q Consensus       405 ~~~l~-~~i~~yE~eg~W~kAL~~Yd~~l~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~e~~~~~~~~~~GlmrcL~~LG  483 (1464)
                      ...++ .+++.+||+++|.+||..||..-.                  .|+             . ....|.+++|++.|
T Consensus      1793 ~~~~~~~~l~~~~he~~w~~aL~~~d~~~~------------------~~s-------------s-~~~~~~~~sLq~~g 1840 (2806)
T KOG0892|consen 1793 PTSLKNLILITAEHEKNWPRALSYYDLADM------------------YPS-------------S-EDEAGFINSLQNAG 1840 (2806)
T ss_pred             cccccccccchhhhhhhHHHHHHhhcchhh------------------ccc-------------h-HhHhHHHHHHHHhc
Confidence            77777 689999999999999999998653                  133             1 12379999999999


Q ss_pred             hhhHHHHhhhccccccCCCCCCcchhHHHHHHHHhcCCCCCcccccCCCCCCCcCcccchhhhhHHHHHHHHhcCChHHH
Q 000483          484 CMHVLDMYCKGLTSWKGQFQHDPEFTKLQYEAAWRTGNWDFSLPYLGANFPSGQNIKSGHFHENLHSCLTALREGDSEEF  563 (1464)
Q Consensus       484 ~~~~L~~~~~gl~~~~~~~~~~~~~~~~~~eaAWrlg~WD~~~~~~~~~~~~~~~~~~~~f~~~L~~~L~al~~~d~~~f  563 (1464)
                      +.|++..|++|++...  ..++++..+..|++|||+|+||...+++-+    +....+..||..+|.+|+|+++++++++
T Consensus      1841 ~~~I~~~y~~Gl~~~~--~~~~~~~~e~~Ye~awr~g~Wd~~t~~~~~----~~~~~~~~y~e~~f~~l~al~ere~e~~ 1914 (2806)
T KOG0892|consen 1841 FFHILEFYIDGLKSND--KIDEPSNEELVYEAAWRLGKWDILTLSLVD----QNKTKGDYYHESLFEALRALHEREIEGS 1914 (2806)
T ss_pred             chhHHHHHhcChhhhh--hhhhhhhhhhhHHHHHhcCCcccCCcchhh----hhhhhchhHHHHHHHHHHHHHHHHHhhh
Confidence            9999999999998875  567788889999999999999986543311    1445677899999999999999999999


Q ss_pred             HHHHHHHHHHHHHHhhhhhhhhHHHHHHHHHHHHHHhHHHHHHHhhhhccCCccccccccccccCCCCCcchhhhhHHHH
Q 000483          564 YRKLKHSKQELVLSVACASEESTEYIYSAIVKLQILCHLGVAWDIRWKSSGESINIYPEKQKIVSEPVIPTVGQLSWLNT  643 (1464)
Q Consensus       564 ~~~i~~aR~~l~~~Ls~~s~ES~~~~y~~lvrLq~L~ELe~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  643 (1464)
                      ..+++.+|+..+..++..+.|+....|+.+.+||.+.+||.+.++.+....                    ......+..
T Consensus      1915 yl~le~a~~~~v~~i~~~see~~~~~y~~l~~L~~l~~l~~i~~l~~~~~~--------------------~~~~~~~~~ 1974 (2806)
T KOG0892|consen 1915 YLHLEDARNKKVLLINPNSEESSLSFYATLYDLQFLVTLEPIRCLQSTADK--------------------HQSNTDILQ 1974 (2806)
T ss_pred             HHHHHHHHHHHHHHhcccchHHHHHHHHHHHHHHHHhhhhhhHhhhhhhcc--------------------hhhhhHHHH
Confidence            999999999999999999999999999999999999999999998663220                    111233445


Q ss_pred             HHHHHHHhhhhchhhhhhHHHHH---------------------HHHHHhcccchHHHHHHHHHHHHHHhcCChhHHHHH
Q 000483          644 EWSSILKRTQLHMNLLEPFMAFR---------------------RVLLQILSCKDFTMQHLLESASTLRKGFRLSQAAAA  702 (1464)
Q Consensus       644 ~W~~rl~~~~~~~~~~EpiL~~R---------------------~~vl~il~~~e~~~~~wl~~a~laRkag~~~~A~~a  702 (1464)
                      .|+.-++.....++..+-....+                     ..++...++....+....+.+.+.++-.+  .+.+.
T Consensus      1975 k~~t~~q~~~~~~~~~~~~~~d~n~l~s~~~l~~~l~~~~~~~~~~~l~~~g~e~~~la~~~~~~~~~~~~~r--~~~~i 2052 (2806)
T KOG0892|consen 1975 KWKTNLQLSSQLMECLSLLIEDRNVLLSLLQLHKQLSESQLADLASLLKYYGLELCKLAESFLIADLLQNIAR--AFPVI 2052 (2806)
T ss_pred             HHHHHHhhccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhHHHHHHHHHhchhhHHhHHH--hhHHH
Confidence            55555554444444333333333                     33333333322222222222222222222  12222


Q ss_pred             HHHHhhhcCCCCCCCchhhhhHHHHHHHHHHHcCChHHHH-------------HHHHHH-HhhccCCCchhHHHHHHHHH
Q 000483          703 LHELKFLYTGPGDQCSTVYWLGRLEEAKLLRAQGQHEMAI-------------NLAKYI-SENYESNEEAPDVYRLVGKW  768 (1464)
Q Consensus       703 L~~l~~l~~~~~~q~~~~~~~~~lE~Ak~lW~~Ge~~~Ai-------------~~Lk~l-~~~~~~~~~~a~~~~llG~w  768 (1464)
                      ..+++.++              .++.|+..|+++....+-             -.+... .++...+....++++.+|+|
T Consensus      2053 ~~~~~~~~--------------~~s~aq~~~k~~~~~~~e~iL~~~~~kne~~~~~s~~~~~~~~lk~~~~~~~a~~g~W 2118 (2806)
T KOG0892|consen 2053 MLSIKLLC--------------KFSLAQENLKHDIDKLSEAILWQRDEKNEAIISLSESLAKNNSLKEFPSDIYAVLGKW 2118 (2806)
T ss_pred             HHHHHHHh--------------hhhhhhhhccchhhhhHHHHHHHHHhhhhHHHHHHhhhhhcchhhhhHHHHHHHHHHH
Confidence            33332222              233333333333322222             222211 22223334568899999999


Q ss_pred             HHHhhcCChHHHHHHhhhhhhhcccccccch-hHHHHhhhhhhhhHHHhHHHHHHhHHHHhhhHHHHHHHHHHHhhHHHH
Q 000483          769 LAESRSSNSRIILENYLKPAVSFSEDQRTTD-KKSIERQCQTHFHLAHYADALFKSYEERLASNEWQAAMRLRKHKTIEL  847 (1464)
Q Consensus       769 lae~~~e~~~~I~~~Y~~~a~~~~~~~~~~~-~~~~~~~~~~~~~lA~f~D~~~~~~~~~~~~~~~~~~~~~~~~~~~el  847 (1464)
                      ++|++++++..|+++|+++|+.+++.++... ++.......+++++|+|.|.+|+.+++|+++.+|+.+++++++.++++
T Consensus      2119 laetk~ens~~i~e~yl~~a~~~ae~~d~e~~~~~~~~~s~a~~~~akysd~~~~~~~~~~~sse~et~~~l~k~~~~~~ 2198 (2806)
T KOG0892|consen 2119 LAETKSENSALISEKYLEKAVSLAEHYDNESCKALIYCQSFAQFCLAKYSDPDYQEDEERRSSSEFETLKDLQKLERSTV 2198 (2806)
T ss_pred             HHHhhccchhhhHHHHHHHHHHHhhhcchhHHHHHHhHHHHHHHHHHhccCchhhhHHHHHhHHHHhhHHHHHHHHHhhh
Confidence            9999999999999999999999888763322 223344578999999999999999999999999999999999999888


Q ss_pred             HHHHHHhhhcCcCccchhhHHHHHHHHHHhhhHHHHHHhHHhHHHHHHHHHHHHHHHhccCCCccHHHHHHHHHHhhhcC
Q 000483          848 EALIKRLKSSTKGEKTDYSIKIQELQKQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLS  927 (1464)
Q Consensus       848 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~e~~~l~~~~~~fl~~Al~~Yl~sL~~~~~~~~~~~~RllsLWl~~~  927 (1464)
                      +.+.++-....       +.+..+.++++.+|+++++++..+|.+||..|++||++|+..|++|+...++|+|+|||+++
T Consensus      2199 ~~~~er~~q~~-------~~~~~~~~rq~~lDe~~l~~l~~~r~~fL~~Alt~Yl~cl~~~~~~D~~~i~R~cslWfsns 2271 (2806)
T KOG0892|consen 2199 EASNEREEQMR-------KNHHVRVQRQLILDEEELLALSEDRSKFLTLALTNYLNCLSESDEYDVDLIFRCCSLWFSNS 2271 (2806)
T ss_pred             hhhHHHHHHHH-------HHHHHHHHHHHhccHHHHHHHHHHHHHHHHHHHHhHHHHHhhcccccHHHHHHHhhhhcccc
Confidence            86654432211       13445778999999999999999999999999999999999999999989999999999999


Q ss_pred             chHHHHHHHHHhhhcccccchhhhhhhhhccccCCccccccccHHHHHHHHHHHHHHhCCchhhhhHhhcccccc-chhh
Q 000483          928 SRQNVIKNMVDTIDEVQSYKFIPLVYQIASRMGSTKDALGLHNFQFALVSLVKKMAIDHPYHTIFQLLALANGDR-IKDK 1006 (1464)
Q Consensus       928 ~~~~v~~~~~~~l~~vPs~kfl~~ipQL~sRL~~~~~~~~~~~f~~~L~~Ll~~i~~~hP~~~l~~l~~~~~~~~-~~~~ 1006 (1464)
                      +..+++..|.+.+.+||+|||+||++||+|||+.    .++..||+.|..|+.|++++||||++|+|+++.+..+ .++.
T Consensus      2272 ~~~evn~~mk~~i~~ipsyKFip~~yQlAaRl~~----~~~~~fq~~L~~Li~r~~~dhPyhtly~L~~L~~~~rd~e~~ 2347 (2806)
T KOG0892|consen 2272 HLKEVNNSLKHEIQTVPSYKFIPLVYQLAARLGN----SENNSFQKSLTSLIYRVGRDHPYHTLYQLLSLVNAVRDNEDE 2347 (2806)
T ss_pred             chHHHHHHHHHHhccCCcchhHHHHHHHHHHhcc----ccCchHHHHHHHHHHHHhccCchHHHHHHHHHHhcCcChhhh
Confidence            9999999999999999999999999999999993    2467899999999999999999999999999998876 5666


Q ss_pred             hccccchhhhhhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHHhcccccccccccchhhhh--hhccccccccc
Q 000483         1007 QRSRNSFVVDMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYIKLAELETRREQDTNKRIQLPREIR--CLRQLELVPVV 1084 (1464)
Q Consensus      1007 ~~~~~~~~~~~~~~~~a~~il~~l~~~~~~~~~~~~~l~~~~~~la~~~~~~~~~~~~~~~~~~~l~--~l~~l~~~p~~ 1084 (1464)
                      .++|.+  ++.+|..+++.++.......++++++++.+|++|+.||+.++.......+.+.+|....  +..+++.+|+|
T Consensus      2348 n~sr~s--l~~~rki~a~l~~~~v~~~~~~~v~~v~~lc~~yI~lAnl~~~q~~t~~k~v~~p~~~~~~K~~nl~~v~~p 2425 (2806)
T KOG0892|consen 2348 NRSRGS--IDRDRKIAAELDLCDVNQGAGNMVRQLECLCEAYISLANLKTSQNDTTSKLVRLPGYQWFLKQLNLEGVPPP 2425 (2806)
T ss_pred             hhcccc--cchhHHHHHHHhhhHhhccchhHHHHHHHHHHHHHHHhcCcccccchhhhhhcCccccHHHhhhhccCCCCC
Confidence            777776  78899999999999988889999999999999999999976655422223366776544  45567789999


Q ss_pred             ccccCCCCCCcccCCCccccccccceEEEecCCCCceEEEEEcCCCceeeEEEecCccchhHHHHHHHHHHHHHHHHhhC
Q 000483         1085 TATVPIDCTCQYNEGSFPYFKGLAESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNH 1164 (1464)
Q Consensus      1085 t~~lp~~~~~~y~~~~~~~i~~f~~~~~v~~s~~~Pk~i~~~gsdG~~y~~L~K~G~dDlRqD~r~~Qlf~liN~lL~~~ 1164 (1464)
                      |+++++++++.|  +++|+|.+|.++|.+++|++.||+|+|+||||++|++|+|+|+||||||++|+|+|+++|++|.++
T Consensus      2426 T~ev~v~~s~~~--~~~p~i~s~~~~v~~~~GinaPkiI~c~gSDG~~~kqLVK~gnDDLRQDAVMeQvF~~vN~lL~~~ 2503 (2806)
T KOG0892|consen 2426 TMNVKVNDSGDY--GNIPTVVSFDDTVTFAGGINAPKVITCVGSDGKTYKQLVKGGNDDLRQDAVMEQVFGQVNTFLQND 2503 (2806)
T ss_pred             CCCccccCCccc--CCCceEEecccceeeecCccCCeEEEEEccCchhHHHHHhcccchHHHHHHHHHHHHHHHHHhhcc
Confidence            999999887755  568999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCceeccceEEEcCCCCceeEEcCCCCchHHHhhhhccCCCCCCCcCCCcchhHHHHhhhcchH-----hHHHHH
Q 000483         1165 RDTWKRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREHMSNVK-----DKRIAF 1239 (1464)
Q Consensus      1165 ~et~~r~L~i~tY~ViPLs~~~GlIE~v~~t~tl~~il~~~~~~~~~~~r~~~~~~~~~~~r~~~~~~~-----~k~~~f 1239 (1464)
                      ++|++|+|.||||+||||+|++|+||||.||+|+++++....  +|+|+||+|+||++.+||+.|++.+     +|+++|
T Consensus      2504 ~et~krkL~irTYKVvPls~~sGvlEwv~~tiplgeyLv~~~--~gah~ry~p~d~s~~~crk~m~~~q~k~~E~r~k~y 2581 (2806)
T KOG0892|consen 2504 RETRKRKLSIRTYKVIPLSPKAGVLEWVTNTIPLGEYLVVES--GGAHKRYRPNDWSLSKCRKLMSEVQKKSLETRLKAY 2581 (2806)
T ss_pred             HHHHhcccceeEEeeeecCcccceeecccCCeehhhhhcccC--CccccccCCCCCChHHHHHHHHHHhcccHHHHHHHH
Confidence            999999999999999999999999999999999999997543  8999999999999999999998776     899999


Q ss_pred             HHHHhhhhhhHHHHHHHHcCCchHHHHHHHHHHHhhcccchhhheeccCCCCCCeeEEecCCCeEEEeecccccccccCC
Q 000483         1240 QEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLGVAFEQGLML 1319 (1464)
Q Consensus      1240 ~~i~~~~~pvl~~~f~~~f~~~~~w~~~R~~ft~S~A~~S~vgyilgLGDRH~~NILld~~tG~v~hIDfg~~f~~g~~l 1319 (1464)
                      .+||.+|.||||+||+++||+|.+||++|++||||+|+.|||||||||||||.+|||||..||+|||||||++||+|+.+
T Consensus      2582 ~~vc~n~~PvfryFflEkF~dP~~WFekrlaYTrsvA~sS~VGyILGLGDRH~qNILid~~taEviHIDlGiAFEQGkil 2661 (2806)
T KOG0892|consen 2582 DKVCRNIRPVFRYFFLEKFPDPADWFEKRLAYTRSVAASSMVGYILGLGDRHGQNILIDQQTAEVIHIDLGIAFEQGKIL 2661 (2806)
T ss_pred             HHHHhhchHHHHHHHHHhcCCHHHHHHHHHHHHHhHHHHHHHHHHhcccchhhhheeecccccceEEEeeeeehhcCCcC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccccccccccccccchhHHHHHHHHHHHhcChHHHHHHHHHHccCCCcccccChhHHHhhhhcccccccC
Q 000483         1320 KTPERVPFRLTRDIIDGMGVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKALQRQKEMDDDLET 1399 (1464)
Q Consensus      1320 ~~pE~VPFRLT~niv~~mG~~g~eG~F~~~~~~t~~~Lr~~~~~l~~iL~~f~~DpL~~W~~~~~~~~~~~~~~~~~~~~ 1399 (1464)
                      |+||+|||||||+||||||++||||+||+|||.||.+||++++.+++|||+|+||||++|.++|.|+.++|++ ++..+.
T Consensus      2662 ptPE~VPFRLTRDiVdgmGItGveGvFrRccE~t~~vlR~~~~~lltileVl~yDPLf~W~msplK~~~~q~~-e~~e~~ 2740 (2806)
T KOG0892|consen 2662 PTPETVPFRLTRDIVDGMGITGVEGVFRRCCEFTLEVLRREKESLLTILEVLLYDPLFSWLMSPLKALKKQKE-EDEENF 2740 (2806)
T ss_pred             CCCCcccceeehhhccccCccCchHHHHHHHHHHHHHHHhhhHHHHHHHHHHHhcchHHHhhcHHHHHHHHHh-hcchhc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999986 333333


Q ss_pred             CCCCCcccccc-chhHHHHHHHHHhhhcCCCCCCCcCHHHHHHHHHHHccCchhhhhhCcccccCC
Q 000483         1400 GLEGPEDEYEG-NKDAERALIRVKQKLDGYEGGEMRSVHGQVQQLIQDAIDPERFCLMFPGWGAWL 1464 (1464)
Q Consensus      1400 ~~~~~~~~~~~-n~~a~~~l~rv~~KL~g~~~~~~lsv~~qV~~LI~~Atd~~NLa~m~~gW~pwl 1464 (1464)
                      +.++..+.... +..|.|++.|+.+||.|++.|..+||++||++||||||||.|||+|||||.||+
T Consensus      2741 n~~~~~~~~~~nd~~a~r~l~r~q~kl~g~e~g~~~sVe~qv~~LIqqA~dpsnLs~~fpGW~a~~ 2806 (2806)
T KOG0892|consen 2741 NLSGNITEDASNDRNAVRALMRAQRKLDGVEQGTMLSVEAQVQELIQQATDPSNLSLMFPGWSAFQ 2806 (2806)
T ss_pred             ccccchhhhhccchHHHHHHHHHHHHhhhhhccccccHHHHHHHHHHHhcCchhhhhhcCCCcCcC
Confidence            43333333333 578999999999999999999999999999999999999999999999999996



>KOG0890 consensus Protein kinase of the PI-3 kinase family involved in mitotic growth, DNA repair and meiotic recombination [Signal transduction mechanisms; Chromatin structure and dynamics; Replication, recombination and repair; Cell cycle control, cell division, chromosome partitioning] Back     alignment and domain information
>KOG0891 consensus DNA-dependent protein kinase [Replication, recombination and repair] Back     alignment and domain information
>COG5032 TEL1 Phosphatidylinositol kinase and protein kinases of the PI-3 kinase family [Signal transduction mechanisms / Cell division and chromosome partitioning / Chromatin structure and dynamics / DNA replication, recombination, and repair / Intracellular trafficking and secretion] Back     alignment and domain information
>KOG0889 consensus Histone acetyltransferase SAGA, TRRAP/TRA1 component, PI-3 kinase superfamily [Signal transduction mechanisms; Chromatin structure and dynamics; Replication, recombination and repair; Cell cycle control, cell division, chromosome partitioning] Back     alignment and domain information
>cd05171 PIKKc_ATM Ataxia telangiectasia mutated (ATM), catalytic domain; The ATM catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05170 PIKKc_SMG1 Suppressor of morphogenetic effect on genitalia-1 (SMG-1), catalytic domain; The SMG-1 catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05163 TRRAP TRansformation/tRanscription domain-Associated Protein (TRRAP), pseudokinase domain; The TRRAP catalytic domain is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05169 PIKKc_TOR TOR (Target of rapamycin), catalytic domain; The TOR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05172 PIKKc_DNA-PK DNA-dependent protein kinase (DNA-PK), catalytic domain; The DNA-PK catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd00892 PIKKc_ATR ATR (Ataxia telangiectasia and Rad3-related), catalytic domain; The ATR catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05164 PIKKc Phosphoinositide 3-kinase-related protein kinase (PIKK) subfamily, catalytic domain; The PIKK catalytic domain subfamily is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd00142 PI3Kc_like Phosphoinositide 3-kinase (PI3K)-like family, catalytic domain; The PI3K-like catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd00891 PI3Kc Phosphoinositide 3-kinase (PI3K), catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd00896 PI3Kc_III Phosphoinositide 3-kinase (PI3K), class III, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05166 PI3Kc_II Phosphoinositide 3-kinase (PI3K), class II, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05165 PI3Kc_I Phosphoinositide 3-kinase (PI3K), class I, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05168 PI4Kc_III_beta Phosphoinositide 4-kinase (PI4K), Type III, beta isoform, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05177 PI3Kc_C2_gamma Phosphoinositide 3-kinase (PI3K), class II, gamma isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>smart00146 PI3Kc Phosphoinositide 3-kinase, catalytic domain Back     alignment and domain information
>cd00894 PI3Kc_IB_gamma Phosphoinositide 3-kinase (PI3K), class IB, gamma isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05174 PI3Kc_IA_delta Phosphoinositide 3-kinase (PI3K), class IA, delta isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd00893 PI4Kc_III Phosphoinositide 4-kinase (PI4K), Type III, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05176 PI3Kc_C2_alpha Phosphoinositide 3-kinase (PI3K), class II, alpha isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05173 PI3Kc_IA_beta Phosphoinositide 3-kinase (PI3K), class IA, beta isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>PF00454 PI3_PI4_kinase: Phosphatidylinositol 3- and 4-kinase; InterPro: IPR000403 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases Back     alignment and domain information
>cd05167 PI4Kc_III_alpha Phosphoinositide 4-kinase (PI4K), Type III, alpha isoform, catalytic domain; The PI4K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd00895 PI3Kc_C2_beta Phosphoinositide 3-kinase (PI3K), class II, beta isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>cd05175 PI3Kc_IA_alpha Phosphoinositide 3-kinase (PI3K), class IA, alpha isoform, catalytic domain; The PI3K catalytic domain family is part of a larger superfamily that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and RIO kinases Back     alignment and domain information
>KOG0905 consensus Phosphoinositide 3-kinase [Signal transduction mechanisms] Back     alignment and domain information
>KOG0906 consensus Phosphatidylinositol 3-kinase VPS34, involved in signal transduction [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] Back     alignment and domain information
>PF02259 FAT: FAT domain; InterPro: IPR003151 The FAT domain is a domain present in the PIK-related kinases Back     alignment and domain information
>KOG0904 consensus Phosphatidylinositol 3-kinase catalytic subunit (p110) [Signal transduction mechanisms] Back     alignment and domain information
>KOG0902 consensus Phosphatidylinositol 4-kinase [Signal transduction mechanisms] Back     alignment and domain information
>KOG0903 consensus Phosphatidylinositol 4-kinase, involved in intracellular trafficking and secretion [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] Back     alignment and domain information
>PTZ00303 phosphatidylinositol kinase; Provisional Back     alignment and domain information
>PF02260 FATC: FATC domain; InterPro: IPR003152 The FATC domain is found at the C-terminal end of the PIK-related kinases Back     alignment and domain information
>KOG0892 consensus Protein kinase ATM/Tel1, involved in telomere length regulation and DNA repair [Signal transduction mechanisms; Chromatin structure and dynamics; Replication, recombination and repair; Cell cycle control, cell division, chromosome partitioning] Back     alignment and domain information
>TIGR02917 PEP_TPR_lipo putative PEP-CTERM system TPR-repeat lipoprotein Back     alignment and domain information
>smart00145 PI3Ka Phosphoinositide 3-kinase family, accessory domain (PIK domain) Back     alignment and domain information
>TIGR02917 PEP_TPR_lipo putative PEP-CTERM system TPR-repeat lipoprotein Back     alignment and domain information
>cd00870 PI3Ka_III Phosphoinositide 3-kinase (PI3K) class III, accessory domain (PIK domain); PIK domain is conserved in all PI3 and PI4-kinases Back     alignment and domain information
>cd00872 PI3Ka_I Phosphoinositide 3-kinase (PI3K) class I, accessory domain ; PIK domain is conserved in all PI3 and PI4-kinases Back     alignment and domain information
>PLN03218 maturation of RBCL 1; Provisional Back     alignment and domain information
>cd00864 PI3Ka Phosphoinositide 3-kinase family, accessory domain (PIK domain); PIK domain is conserved in PI3 and PI4-kinases Back     alignment and domain information
>PLN03081 pentatricopeptide (PPR) repeat-containing protein; Provisional Back     alignment and domain information
>PRK10747 putative protoheme IX biogenesis protein; Provisional Back     alignment and domain information
>PF00613 PI3Ka: Phosphoinositide 3-kinase family, accessory domain (PIK domain); InterPro: IPR001263 Phosphatidylinositol 3-kinase (PI3-kinase) (2 Back     alignment and domain information
>PRK15174 Vi polysaccharide export protein VexE; Provisional Back     alignment and domain information
>cd00869 PI3Ka_II Phosphoinositide 3-kinase (PI3K) class II, accessory domain (PIK domain); PIK domain is conserved in all PI3 and PI4-kinases Back     alignment and domain information
>PLN03218 maturation of RBCL 1; Provisional Back     alignment and domain information
>PRK11447 cellulose synthase subunit BcsC; Provisional Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query1464
2y3a_A1092 Crystal Structure Of P110beta In Complex With Icsh2 8e-11
2x6f_A696 The Crystal Structure Of The Drosophila Class Iii P 3e-09
3ihy_A600 Human Pik3c3 Crystal Structure Length = 600 2e-08
3ls8_A614 Crystal Structure Of Human Pik3c3 In Complex With 3 2e-08
1e8x_A961 Structural Insights Into Phoshoinositide 3-Kinase E 5e-07
1e7u_A961 Structure Determinants Of Phosphoinositide 3-Kinase 5e-07
3nzs_A954 Structure-Based Optimization Of Pyrazolo -Pyrimidin 4e-06
1he8_A965 Ras G12v-Pi 3-Kinase Gamma Complex Length = 965 4e-06
3l54_A966 Structure Of Pi3k Gamma With Inhibitor Length = 966 4e-06
1e8y_A966 Structure Determinants Of Phosphoinositide 3-Kinase 4e-06
3dbs_A960 Structure Of Pi3k Gamma In Complex With Gdc0941 Len 4e-06
3cst_A966 Crystal Structure Of Pi3k P110gamma Catalytical Dom 4e-06
4dk5_A959 Crystal Structure Of Human Pi3k-Gamma In Complex Wi 4e-06
3ene_A959 Complex Of Pi3k Gamma With An Inhibitor Length = 95 4e-06
3qaq_A960 Crystal Structure Of Pi3k-Gamma In Complex With Tri 5e-06
3apc_A966 Crystal Structure Of Human Pi3k-Gamma In Complex Wi 5e-06
4anv_A980 Complexes Of Pi3kgamma With Isoform Selective Inhib 5e-06
4anu_A980 Complexes Of Pi3kgamma With Isoform Selective Inhib 5e-06
4anx_A980 Complexes Of Pi3kgamma With Isoform Selective Inhib 1e-05
4ajw_A934 Discovery And Optimization Of New Benzimidazole- An 2e-05
2wxf_A940 The Crystal Structure Of The Murine Class Ia Pi 3-K 2e-05
3zim_A940 Discovery Of A Potent And Isoform-selective Targete 9e-05
3hhm_A1091 Crystal Structure Of P110alpha H1047r Mutant In Com 1e-04
3hiz_A1096 Crystal Structure Of P110alpha H1047r Mutant In Com 1e-04
2rd0_A1096 Structure Of A Human P110alpha/p85alpha Complex Len 1e-04
4a55_A1096 Crystal Structure Of P110alpha In Complex With Ish2 1e-04
>pdb|2Y3A|A Chain A, Crystal Structure Of P110beta In Complex With Icsh2 Of P85beta And The Drug Gdc-0941 Length = 1092 Back     alignment and structure

Iteration: 1

Score = 66.6 bits (161), Expect = 8e-11, Method: Compositional matrix adjust. Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 26/164 (15%) Query: 1271 YTRSVAASSMVGYIVGLGDRHAMNILIDQATAEVVHIDLG---VAFEQGLMLKTPERVPF 1327 +T S A + Y++G+GDRH+ NI++ + T ++ HID G F+ +K ERVPF Sbjct: 923 FTLSCAGYCVASYVLGIGDRHSDNIMV-KKTGQLFHIDFGHILGNFKSKFGIKR-ERVPF 980 Query: 1328 RLTRDIIDGM-----GVTGVEGVFRRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALS 1382 LT D I + G T G FR+CCE ++R + +T+ + + L Sbjct: 981 ILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALML-----TAGLP 1035 Query: 1383 PLKALQRQKEMDDDLETGLEGPEDEYEGNKDAERALIRVKQKLD 1426 L +++ + + D L G K E AL + KQK D Sbjct: 1036 ELTSVKDIQYLKDSLALG-----------KSEEEALKQFKQKFD 1068
>pdb|2X6F|A Chain A, The Crystal Structure Of The Drosophila Class Iii Pi3-Kinase Vps34 In Complex With 3-Methyladenine Length = 696 Back     alignment and structure
>pdb|3IHY|A Chain A, Human Pik3c3 Crystal Structure Length = 600 Back     alignment and structure
>pdb|3LS8|A Chain A, Crystal Structure Of Human Pik3c3 In Complex With 3-[4-(4- Morpholinyl)thieno[3,2-D]pyrimidin-2-Yl]-Phenol Length = 614 Back     alignment and structure
>pdb|1E8X|A Chain A, Structural Insights Into Phoshoinositide 3-Kinase Enzymatic Mechanism And Signalling Length = 961 Back     alignment and structure
>pdb|3NZS|A Chain A, Structure-Based Optimization Of Pyrazolo -Pyrimidine And -Pyridine Inhibitors Of Pi3-Kinase Length = 954 Back     alignment and structure
>pdb|1HE8|A Chain A, Ras G12v-Pi 3-Kinase Gamma Complex Length = 965 Back     alignment and structure
>pdb|3L54|A Chain A, Structure Of Pi3k Gamma With Inhibitor Length = 966 Back     alignment and structure
>pdb|1E8Y|A Chain A, Structure Determinants Of Phosphoinositide 3-Kinase Inhibition By Wortmannin, Ly294002, Quercetin, Myricetin And Staurosporine Length = 966 Back     alignment and structure
>pdb|3DBS|A Chain A, Structure Of Pi3k Gamma In Complex With Gdc0941 Length = 960 Back     alignment and structure
>pdb|3CST|A Chain A, Crystal Structure Of Pi3k P110gamma Catalytical Domain In Complex With Organoruthenium Inhibitor E5e2 Length = 966 Back     alignment and structure
>pdb|4DK5|A Chain A, Crystal Structure Of Human Pi3k-Gamma In Complex With A Pyridyl- Triazine Inhibitor Length = 959 Back     alignment and structure
>pdb|3ENE|A Chain A, Complex Of Pi3k Gamma With An Inhibitor Length = 959 Back     alignment and structure
>pdb|3QAQ|A Chain A, Crystal Structure Of Pi3k-Gamma In Complex With Triazine-Benzimidazole 1 Length = 960 Back     alignment and structure
>pdb|3APC|A Chain A, Crystal Structure Of Human Pi3k-Gamma In Complex With Ch5132799 Length = 966 Back     alignment and structure
>pdb|4ANV|A Chain A, Complexes Of Pi3kgamma With Isoform Selective Inhibitors Length = 980 Back     alignment and structure
>pdb|4ANU|A Chain A, Complexes Of Pi3kgamma With Isoform Selective Inhibitors. Length = 980 Back     alignment and structure
>pdb|4ANX|A Chain A, Complexes Of Pi3kgamma With Isoform Selective Inhibitors Length = 980 Back     alignment and structure
>pdb|4AJW|A Chain A, Discovery And Optimization Of New Benzimidazole- And Benzoxazole- Pyrimidone Selective Pi3kbeta Inhibitors For The Treatment Of Phosphatase And Tensin Homologue (Pten)-Deficient Cancers Length = 934 Back     alignment and structure
>pdb|2WXF|A Chain A, The Crystal Structure Of The Murine Class Ia Pi 3-Kinase P110delta In Complex With Pik-39. Length = 940 Back     alignment and structure
>pdb|3ZIM|A Chain A, Discovery Of A Potent And Isoform-selective Targeted Covalent Inhibitor Of The Lipid Kinase Pi3kalpha Length = 940 Back     alignment and structure
>pdb|3HHM|A Chain A, Crystal Structure Of P110alpha H1047r Mutant In Complex With Nish2 Of P85alpha And The Drug Wortmannin Length = 1091 Back     alignment and structure
>pdb|3HIZ|A Chain A, Crystal Structure Of P110alpha H1047r Mutant In Complex With Nish2 Of P85alpha Length = 1096 Back     alignment and structure
>pdb|2RD0|A Chain A, Structure Of A Human P110alpha/p85alpha Complex Length = 1096 Back     alignment and structure
>pdb|4A55|A Chain A, Crystal Structure Of P110alpha In Complex With Ish2 Of P85alpha And The Inhibitor Pik-108 Length = 1096 Back     alignment and structure

Structure Templates Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query1464
3ls8_A614 Phosphatidylinositol 3-kinase catalytic subunit ty 1e-30
1e7u_A961 Phosphatidylinositol 3-kinase catalytic subunit; p 6e-27
2y3a_A1092 Phosphatidylinositol-4,5-bisphosphate 3-kinase Ca 2e-22
2x6h_A696 GH13170P, VPS34, phosphotidylinositol 3 kinase 59F 3e-22
2wxf_A940 Phosphatidylinositol-4,5-bisphosphate 3-kinase Ca 2e-21
3hhm_A1091 Phosphatidylinositol-4,5-bisphosphate 3-kinase cat 4e-21
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 8e-18
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 1e-11
1vt4_I1221 APAF-1 related killer DARK; drosophila apoptosome, 1e-11
1vt4_I1221 APAF-1 related killer DARK; drosophila apoptosome, 8e-10
1vt4_I1221 APAF-1 related killer DARK; drosophila apoptosome, 9e-10
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 3e-05
1w1n_A33 Phosphatidylinositol 3-kinase TOR1; target of rapa 2e-07
3lvg_D190 LCB, clathrin light chain B; SELF assembly, coated 3e-04
>3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A Length = 614 Back     alignment and structure
 Score =  128 bits (323), Expect = 1e-30
 Identities = 86/526 (16%), Positives = 180/526 (34%), Gaps = 65/526 (12%)

Query: 874  KQLAMDREEAQKLLDDRDNFLGLALEGYKRCLVIGDKYDVRVVFRLVSLWFSLSSRQNVI 933
            ++ A+ R    +  D+      L L    +     D  +     +  S   S+S   +  
Sbjct: 112  RRYAVARLR--QADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDS-QSSVSENVSNS 168

Query: 934  KNMVDTIDEVQSYKFIPLVYQIASRMGSTKDALGLHNFQFALVSLVKKMAIDHPY--HTI 991
                  ID  Q                 TK+     N +  L + +   A  +    + +
Sbjct: 169  GINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYL 228

Query: 992  FQLLA--LANGDRIKDKQRSRNSFVVDMDKKLAAENLLEELSSYHGAIIRQMKQMVDVYI 1049
            +  +     + D  +   ++   ++  M +   A    ++      +++   +  VD  +
Sbjct: 229  YWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLV 288

Query: 1050 KLAELETRREQDTNKRIQLPREIRC-LRQLELVPVVTATVPIDCTCQYNEGSFPYFKGLA 1108
             L +   R   +  K+ +  + +     ++ L  V    +P++               + 
Sbjct: 289  HLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLE-------PQVKIRGIIP 341

Query: 1109 ESVMVMNGINAPKVVECFGSDGHKYRQLAKSGNDDLRQDAVMEQFFGLVNTFLRNHRDTW 1168
            E+  +      P  +     DG KY  + K G+D LRQD ++ Q   L++  LR      
Sbjct: 342  ETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDD-LRQDQLILQIISLMDKLLRKE---- 396

Query: 1169 KRRLGVRTYKVVPFTPSAGILEWVDGTVPLGDYLIGSTRNGGAHGRYGIGDWSFLKCREH 1228
               L +  YKV+  +   G ++++         +       G+   +             
Sbjct: 397  NLDLKLTPYKVLATSTKHGFMQFIQSVP-----VAEVLDTEGSIQNF------------- 438

Query: 1229 MSNVKDKRIAFQEVCENFRPVLHYFFLERFLQPAYWFEKRLAYTRSVAASSMVGYIVGLG 1288
                                    +            E    Y +S A   ++ YI+G+G
Sbjct: 439  ---------------------FRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVG 477

Query: 1289 DRHAMNILIDQATAEVVHIDLGVAFEQGLMLKTPERVPFRLTRDIIDGMGVTGVEG--VF 1346
            DRH  N+L+ + T ++ HID G    +      P   P +L +++++GMG T  E    F
Sbjct: 478  DRHLDNLLLTK-TGKLFHIDFGYILGRD---PKPLPPPMKLNKEMVEGMGGTQSEQYQEF 533

Query: 1347 RRCCEKTLSVMRTNKEALLTIVEVFIHDPLYKWALSPLKALQRQKE 1392
            R+ C      +R     +L +  + +   +   AL P K +++ ++
Sbjct: 534  RKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQD 579


>2y3a_A Phosphatidylinositol-4,5-bisphosphate 3-kinase Ca subunit beta isoform; transferase, phosphoinositide 3-kinase, RTK; HET: GD9; 3.30A {Mus musculus} Length = 1092 Back     alignment and structure
>2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* Length = 696 Back     alignment and structure
>2wxf_A Phosphatidylinositol-4,5-bisphosphate 3-kinase Ca subunit delta isoform; transferase, phosphoprotein, isoform-specific inhibitors; HET: 039; 1.90A {Mus musculus} PDB: 2wxg_A* 2wxh_A* 2wxi_A* 2wxj_A* 2wxk_A* 2wxl_A* 2wxm_A* 2wxn_A* 2wxo_A* 2wxp_A* 2wxq_A* 2wxr_A 2x38_A* Length = 940 Back     alignment and structure
>3hhm_A Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform; PI3KCA, PI3K, PIK3R1, phosphatidilynositol 3,4,5- triphosphate, wortmannin, H1047R, ATP-binding, disease mutation, kinase; HET: KWT; 2.80A {Homo sapiens} PDB: 3hiz_A 2rd0_A 4a55_A* 2enq_A Length = 1091 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1w1n_A Phosphatidylinositol 3-kinase TOR1; target of rapamycin, Ser/Thr kinase, redox-regulation, disulfide bond, transferase; NMR {Saccharomyces cerevisiae} PDB: 2kio_A 2kit_A Length = 33 Back     alignment and structure
>3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 Back     alignment and structure

Structure Templates Detected by HHsearch ?

No hit with probability above 80.00


Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 1464
d1e7ua4369 d.144.1.4 (A:726-1094) Phoshoinositide 3-kinase (P 2e-55

Homologous Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query1464
d1e7ua4369 Phoshoinositide 3-kinase (PI3K), catalytic domain 100.0
d1e7ua1201 Phoshoinositide 3-kinase (PI3K) helical domain {Pi 88.08